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KAYLA RENEE HILL. The pathogenesis of noise-induced hearing loss is mediated by 
the activation of AMPK via LKB1 and CaMKKβ. (Under the direction of SU-HUA SHA) 
 
Noise-induced hearing loss (NIHL) is a major public health issue and an unresolved 
clinical problem. Here we investigate pathomechanisms of auditory sensory cell death 
and suggest a novel target pathway for intervention. Cellular survival from stress 
depends upon maintenance of energy homeostasis, largely by the adenosine 
monophosphate-activated protein kinase (AMPK) which coordinates metabolic pathways 
with the energy demands of the cell. In response to traumatic noise exposure which 
resulted in hair cell death, levels of p-AMPKα increased in hair cells in a noise intensity-
dependent manner. Inhibition of AMPK via administration of siRNA or a pharmacological 
inhibitor attenuated noise-induced losses of hair cells and synaptic ribbons, and 
preserved auditory sensitivity. The phosphorylation of liver kinase B1 (p-LKB1), an 
AMPK kinase, was increased by noise exposure in cochlear tissues. Additionally, the 
phosphorylation of calcium-calmodulin kinases I and IV (p-CaMKI/IV), the targets of 
calcium-calmodulin kinase kinase beta (CaMKKβ), an alternative AMPK kinase that is 
mediated by calcium, was increased in outer hair cells (OHCs) after the exposure. 
Inhibition of LKB1 or CaMKKβ by siRNA or knockout mice reduced OHC loss and NIHL.  
Finally, the increased p-AMPKα in OHCs after noise exposure was attenuated by 
silencing LKB1 or using CaMKKβ knockout mice. These results indicate that noise 
exposure leads to hair cell death by activating AMPK via LKB1- and CaMKKβ-mediated 
pathways, facilitating the pathogenesis of NIHL.  
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1. The structure and function of the ear 
Hearing is our most sensitive organ and covers a great dynamic range. We are able to 
hear a small sound from a pin dropping onto the floor to the piercing sound of a gunshot. 
Hearing is also discriminative; we can distinguish the fine nuances during a concert.  
Hearing is a complex process that involves the collection of sound wave vibrational 
energy by the ear and the processing of these signals for interpretation by our brain. In 
order to understand the changes of the mammalian auditory organ after exposure to 
sound stimuli, I will take you on the journey through the three anatomical regions of the 
ear: the outer ear, middle ear, and inner ear (Fig. 1).  
 
Figure 1. The anatomical partitions of the ear. The ear consists of 3 main regions:  
the outer, middle and inner ear. The outer ear consists of the pinna and external auditory 
canal, which function to collect sound vibrations, which are then transferred to the middle 
and inner ear. The middle ear begins at the tympanic membrane and consists of the 3 
middle ear ossicles: the malleus, incus and stapes. The inner ear holds the cochlea and 




1.1 The outer and middle ear 
The outer ear consists of two parts. The pinna, the only portion of the ear that is 
externally visible, is primarily made of cartilage and skin and serves as a complicated 
funnel to collect and enhance acoustic stimuli. Air-propagated sound waves are directed 
into the external auditory canal, which conducts sound waves along its length to the 
innermost limit of the canal, the tympanic membrane. The tympanic membrane, more 
commonly known as the ear drum, is the boundary between the outer and middle ear. It 
is a thin, cone-shaped membrane composed of radial fibers that have elastic properties, 
which allow the structure to vibrate in response to acoustic waves. This transfers the 
sound wave energy into vibrational energy, which is transferred to the middle ear via the 
middle ear ossicles. The malleus, the first of the three ossicles, is attached to the medial 
surface of the tympanic membrane and transfers acoustic vibrations to the incus, which, 
in turn, connects to the stapes, forming a chain of ossicles for vibrational energy to pass 
through towards the inner ear. The stapes sits on the oval window, an opening in the 
bony wall of the cochlea that separates the middle ear from the inner ear. The fluid-filled 
labyrinth of the cochlea is located on the medial side of the oval window. The impedance 
mismatch between the air-filled middle ear and fluid-filled inner ear necessitates the 
amplification of sound vibrations to effectively transfer the stimuli between the two 
media. This amplification is achieved by concentrating vibrational energy from the 
surface area of the tympanic membrane to the oval window, which is only 1/20th of its 





1.2 The inner ear 
The inner ear is composed of 2 functionally distinct organs:  the vestibular system and 
the cochlea. The vestibular system is responsible for balance and orientation in three-
dimensional space. The cochlea is dedicated to the detection of sound and will be the 
focus of this dissertation. The cochlea is a bony, spiral shaped structure (Fig. 2).  At its 
core is the spongy bone of the modiolus from which the bony osseous spiral lamina 
winds like a screw for 2.5 turns in humans. The cochlea is separated into three fluid-filled 
cavities by the Reissner’s and basilar membrane:  the scala vestibuli, scala media, and 
scala tympani. The scala vestibuli and scala tympani make up the upper and lower 
labyrinths and are filled with perilymph fluid which is composed of sodium (~145 mM), 
chloride (~120 mM), bicarbonate (~20 mM), potassium (~5 mM) and calcium (~1 mM) 
ions, comparable to cerebrospinal fluid.  
The scala media, also known as the cochlear duct, is located in the middle of 
these two canals. It is enclosed superiorly by the Reissner’s membrane, which forms a 
barrier from the scala vestibule. Inferiorly, the scala media is enclosed by the basilar 
membrane, which borders the scala tympani. The stria vascularis, the specialized 
capillary-rich tissue which adheres to the spiral ligament, adjacent to the outer wall of the 
bony cochlea and forms a lateral barrier. It is the specialized cells of stria vascularis that 
are responsible for the potassium-rich characteristics of the endolymph fluid within the 
scala media (1). The endolymph contrasts with perilymph composition primarily due to 
its low sodium (~1 mM) and calcium (~0.02 mM), and high potassium (~160 mM) 
concentrations. This specialized fluid maintains a high resting endocochlear potential 
(EP) of 70-100 mV in comparison with the low 0-5 mV potential of the perilymph and the 
-70 mV potential of hair cells. This potential difference between the endolymph and the 
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hair cell is the largest electrical potential difference in the body and is essential to the 




Figure 2. Cross-section of the cochlea. A cross section through the bony cochlea 
reveals 3 fluid filled cavities:  scala vestibuli (blue), scala media (red) and scala tympani 
(green). The scala media is filled with endolymph and contains the organ of Corti, the 
sensory organ of the inner ear. The scala tympani and scala vestibuli are filled with 
perilymph. The Reissner’s membrane (RM) separates the scala media from the scala 
vestibuli, while the basilar membrane (BM) provides a barrier for the scala tympani. The 
spiral ganglion neurons of the cochlear nerve (yellow) are situated within the modiolus, 




The stapes sends vibrations through the oval window to the perilymph of the 
scala vestibuli. The vibrational energy is transferred through the apical most point of the 
cochlea where the perilymph of the scala vestibuli meets the scala tympani at the 
helicotrema. The resulting pressure from the vibrations of the incompressible perilymph 
fluid is released at the round window, where it pulses within the bony, inflexible structure 
of the cochlea. The vibration of the fluids causes mechanical movement of the basilar 
membrane. This vibratory pattern, also known as the traveling wave, depends upon the 
characteristics of the basilar membrane, such as width and elasticity. As the basilar 
membrane progresses apically from the base of the cochlea, its thickness increases and 
alters its mechanical properties such as stiffness. Depending on the frequency of the 
auditory stimulus, the site of maximal amplitude of the basilar membrane traveling wave 
varies. Stimulation by high frequencies causes maximal amplitude of the traveling wave 
toward the stapedial or basal end of the basilar membrane, which presents narrow and 
stiff features. On the other hand, low-frequency stimuli causes maximal amplitude of the 
traveling wave near the apical end, where the basilar membrane is more wide and 
flaccid. These progressive changes create a tonotopic gradient that permits humans to 
detect sound frequencies that range from 20 Hz – 20 kHz. On the other hand, the range 
of mouse hearing, the model of focus in this study, extends from 2 – 90 kHz.   
The organ of Corti rests on the basilar membrane within the scala media and 
contains the sensory cells of the cochlea (Fig. 3). It is composed of one row of inner hair 
cells (IHCs) located medially and three rows of outer hair cells (OHCs) located laterally. 
In the human, there are 3,500 IHCs and 12,000 OHCs in the cochlea. The mouse 
sensory epithelium contains 700 IHCs and 2,400 OHCs. The tunnel of Corti is formed by 
the inner and outer pillar cells that separate the two sensory cell groups. Stereocilia 
bundles are embedded at the cuticular plate, the uppermost region of hair cells. These 
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bundles are formed from three rows of stereocilia of graded length that are connected to 
each other via tip links and lateral links. The stereociliary bundles of IHCs and OHCs 
differ in their pattern; the former are in a lateral arrangement and the latter forms a “W” 
pattern.  The OHC stereocilia bundles embed themselves firmly into the gelatinous 
tectorial membrane, while IHC stereocilia are weakly connected. 
The stereocilia at the top of the hair cell play a fundamental role in converting the 
mechanical energy of the basilar membrane into electrical energy of hair cells for 
conversion to neuronal signals. The key step in this process is the deflection of 
stereocilia bundles, which causes the opening of mechanotransduction (MET) channels 
at the tips of the stereocilia of hair cells. The displacement of the basilar membrane 
forms shearing forces against the stereocilia bundles as they move up and down against 
the tectorial membrane. The resulting bend of the stereocilia bundles increases the 
tension of stereocilia tip links, which pulls the MET channels open (Fig. 4). A 
depolarizing current of potassium and calcium ions from the endolymph (-70 mV) flows 
through the MET channels and enters the hair cells (+80 mV). This depolarization opens 
L-type voltage-gated calcium channels (VGCC) in the basolateral region of hair cells that 
subsequently stimulate the influx of calcium proximal to the synaptic cleft, an active 
region that contains synaptic ribbons surrounded by glutamate-filled synaptic vesicles.  
These synaptic ribbons play a key role in the second half of this process by converting 
the changes in hair cell membrane potential to chemical neuronal signals that are sent to 
the brain. The secondary influx of calcium promotes the release of glutamate 
neurotransmitter from synaptic vesicles into the synaptic cleft, which then activates α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR) in afferent 
nerve fibers that innervate the hair cells. The resulting action potential is carried by 




Figure 3. The organ of Corti. The organ of Corti sits above the basilar membrane. The 
stereocilia of the hair cells extend toward the tectorial membrane (pink). The IHCs 
(green) form a single row on the modiolar side and are separated from the 3 rows of 
OHCs (green) by 2 rows of pillar cells (purple) and the tunnel of Corti.  
 
 
Figure 4. Deflection of stereocilia in mechanotransduction. The shearing force of 
the tectorial membrane deflects the stereocilia (pink) of hair cells. This increases tension 
in tip links (helix), which tugs the mechanotrasdution (MET) channels (yellow) open to 
allow potassium and calcium ions (red) to enter.  
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The displacement of the basilar membrane is further amplified by the 
electromotility of OHCs, which allows them to change in length when stimulated. These 
electromotile responses are driven by the voltage-dependent changes in OHCs following 
the opening of mechanotransduction channels. The depolarization of OHCs changes the 
conformation of voltage-sensitive prestin, an OHC specific motor protein. Prestin is 
localized in the lateral plasma membranes of OHCs and alters its shape by binding 
intracellular chloride. In a non-depolarized state, chloride ions allosterically bind to 
prestin, resulting in an elongated shape. Upon basilar membrane displacement and 
subsequent depolarization, chloride ions are dissociated from the prestin binding sites, 
causing OHC contraction. The shape changes of prestin contracts and elongates the 
length of OHCs, and serves to augment the amplitude of the traveling wave at a 
particular frequency, and importantly, increases frequency sensitivity (2). This 
mechanical feedback characteristic has led to the description of OHCs as the cochlear 
amplifier to enhance mechanical stimulation of IHCs. Meanwhile, the IHCs are primarily 
responsible for transducing electrical signals that are sent to the brain. 
The contrasting functions of OHC and IHCs explain the variations in hair cell 
innervation by the two subtypes of spiral ganglion neurons (SGN):  Type I and Type II 
SGNs. Type I SGNs make up the majority (95%) of SGNs. This subset is myelinated and 
exclusively innervates IHCs. Each IHC is innervated by as many as 20 different afferents 
from type I SGN which can be divided into three types in the murine model:  low 
threshold-high spontaneous rate (SR), high threshold-low SR, and average threshold-
average SR. The low threshold-high SR fibers are the most sensitive to noise exposure 
and have small synaptic ribbons, but wide post-synaptic densities. The high threshold-
low SR fibers have large synaptic ribbons and small post-synaptic densities. In contrast, 
10 
 
OHCs are only innervated by a single auditory afferent from Type II SGNs, each of 
which innervate multiple OHCs and make up only 5% of auditory afferents.  
 
2. Sensorineural hearing loss 
According to the World Health Organization, 360 million people or 5.3% of the world 
population have a disabling hearing loss and 15% are hearing impaired (3). Hearing loss 
is divided into two main types: genetic hearing loss and acquired hearing loss. As the 
name points out, genetic hearing loss is associated with inherited hearing loss. Acquired 
hearing loss will be the focus of this dissertation. Acquired hearing loss describes the 
loss of hearing function that develops during an individual’s lifetime as one is exposed to 
various stresses, including viral or bacterial infections, aging, exposure to ototoxic drugs, 
such as the chemotherapeutic cisplatin and aminoglycoside antibiotics, and exposure to 
noise insults. The loss of hearing is mostly due to the fact that, unlike non-mammalian 
vertebrates, mammalian cochlear sensory hair cells lack the ability to regenerate; 
therefore, the loss or damage of mammalian hair cells in the cochlea is permanent and 
results in a permanent sensorineural hearing loss.  
Additionally, other inner ear disorders may also occur as a result of acquired 
hearing loss. Tinnitus, commonly known as ringing in the ear, affects nearly 15% of the 
world population and can severely affect quality of life. Meniere’s disease affects roughly 
1-2% of the world population and causes spontaneous episodes of vertigo and hearing 
loss. Among the numerous reasons of acquired hearing loss, noise exposure, the aging 
process and treatment with ototoxic drugs are the three major causes. For my 




2.1 Noise-induced hearing loss 
Exposure to loud sounds can cause damage to or death of cochlear hair cells, leading to 
noise-induced hearing loss (NIHL).  NIHL is one of the most common causes of acquired 
hearing deficits and is one of the most frequent work-related disabilities in industrialized 
countries (4). Worldwide, 250 million people suffer from NIHL (5). According to the 
National Institute of Occupational Safety and Health (NIOSH), an estimated 30 million 
workers are exposed to potentially hazardous noise from factories, construction sites, 
and airports, in the U.S. alone (6). NIHL has become the most predominant disability in 
war veterans, with an economic impact of $660 million in compensation payments 
annually (7-9). Furthermore, exposure to recreational noise, such as listening to loud 
music on personal listending devices, can also lead to NIHL (10).  
 
2.2 Noise exposure 
The magnitude of hearing loss depends upon the characteristics of noise, including the 
intensity, duration, and temporal characteristics such as continuous noise or impulse 
noise, a short-duration exposure to an intense sound (11). The greater the intensity 
(perceived as loudness) of a sound stimulus, the greater the amount of damage can 
occur to cochlear cells. Sound intensity is measured in decibels (dB), a logarithmic unit 
of sound pressure level (SPL). Typically, normal moderate human conversation occurs 
around 60 dB of intensity. Long or repeated exposures to sounds at 85 dB of intensity 
and above (~300 times the energy level of 60 dB) can result in hearing a loss, thus 
hearing protection is required by the Occupational Safety and Health Administration 
(OSHA) for occupational exposures of 85 dB SPL.  This intensity levels includes some 
everyday sounds that many people may not consider harmful. The noises from a 
lawnmower, for example, can get up to 90 dB of intensity.  At 120 dB of intensity and 
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above instant hearing damage can occur.  Noises such as chain saws and other power 
tools have intensities of 110-120 dB. Around sixty million Americans own firearms, 
exposing themselves to potentially 140-170 dB of noise without the proper use of ear 
protectors.  
Additionally, hearing loss can be induced with shorter exposure durations. 
According to the NIOSH, exposure levels should be controlled in order to limit hazardous 
levels of intensity and duration (12). To calculate the recommended exposure limit 
(REL), the NIOSH generated a formula to combine the damaging effects of intensity 
level (L) and duration (T):  T (min) = 480/2(L-85)/3(12). Using this formula, exposure 
durations of no more than 8 h, a typical work day, is recommended for noise exposure 
levels of 85 dB. On the other hand, shorter duration times of 15 minutes are endorsed 
for exposure intensities of 100 dB. 
 
2.3 Noise-induced cochlear pathology 
NIHL can be divided into two subtypes: temporary hearing loss and permanent hearing 
loss. The characteristic pathological feature of permanent hearing loss is the irreversible 
loss of sensory hair cells, resulting in a loss of hearing function that does not recover. On 
the other hand, lower levels of noise can cause a temporary hearing loss for minutes, 
hours, or days, depending on the parameters of the stimulus (13). 
 
2.4 Noise-induced temporary hearing loss 
At the lower limit of damaging noise, reversible changes can occur, resulting in a 
temporary auditory threshold shift (TTS), or temporary hearing loss that recovers within 
a few days. In TTS, sensory hair cells, including both IHCs and OHCs, are not lost. The 
pathological changes associated with TTS are not well understood.    
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Possible pathologies underlying TTS include swelling, fusion or distortion of 
stereocilia, resulting in detachment of stereocilia from the tectorial membrane or a 
reduction in the stiffness of stereocilia, both of which affect the deflection of stereocilia 
and the subsequent mechanotransduction necessary for hair cell depolarization (14, 15). 
Commonly, repairable excitotoxic effects are detected at the IHC synapses post TTS 
noise exposure. The presence of swollen afferent fibers at the base of IHCs was 
accompanied by vacuolization (16-18). More recently, studies have uncovered delayed 
manifestations of neural degeneration of IHC synaptic ribbons and SGN loss regardless 
of the reversibility of auditory threshold shifts and the absence sensory hair cell damage 
(19-22). Despite the reversible effects of TTS, TTS noise exposure at a young age can 
accelerate the synaptopathy of SGNs leading to age-related neuronal permanent 
hearing loss (23). This observation has challenged the traditional view that degeneration 
of SGNs occurs after sensory hair cell loss.    
 
2.5 Noise-induced permanent hearing loss 
Higher intensities of noise may result in a permanent auditory threshold shift (PTS), or 
permanent hearing loss. This deficit in hearing function is believed to be a result of 
metabolic and mechanical processes that damage the inner ear. Mechanical factors that 
result from extremely high forces of acoustic stimuli cause excessive movement of the 
cochlea, disrupting internal cellular structure, and typically inducing injuries rapidly after 
exposure to the insult. On the other hand, metabolic damage is considered to be a more 
gradual process that exhausts mitochondrial metabolism, alters homeostasis of cochlear 
cells and fluids, increases oxidative stress and induces changes in energy production, 
gene expression and protein synthesis. These changes can have various pathological 
effects, including cell death, excitotoxicity, and structural damage.   
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PTS has several pathological correlates ranging from subtle defects to severe 
lesions. Similar to the histopathology of TTS, stereocilia damage, including collapse, 
breakage and fusion, can also occur under the PTS condition (24-27). Vacuolization in 
the IHC is also common in the PTS condition (28). Furthermore, the innervating afferent 
terminals of IHCs become swollen and degenerate, and at later times, are followed by 
the degeneration of the afferent fibers and SGNs. Additionally, SGNs display a subset of 
swollen satellite cells (28).  
PTS is typically characterized by irreversible loss of sensory hair cells. OHCs are 
more vulnerable than IHCs in the cochlea, but IHCs can also be damaged with 
increased intensity of noise exposure (28). Noise-induced hair cell loss is a frequency-
related damage in humans and in some animal models, such as guinea pig and 
chinchilla; however, in mice and rats, hair cell susceptibility follows a base-to-apex 
pattern as a result of noise-induced tonotopic damage, with basal hair cells being much 
more easily damaged than the apically located cells. In contrast, supporting cell 
structures remain generally well-preserved, although reversible or permanent 
pathologies may occur. After higher intensity noise exposures, and particularly impulse 
noise, supporting cell structures can also be damaged by detachment from the basilar 
membrane or by separation of cell-cell junctions due to mechanical movement of the 
organ of Corti. This can change the impedance of the basilar membrane and affect the 
sensitivity of hearing in that region. These structural disturbances can occur before 
sensory hair cell death. 
 Severe exposures cause permanent degeneration of the fibrocytes of the spiral 
limbus and spiral ligament, of which type II and IV fibrocytes are the most vulnerable 
(28). Additionally, the stria vascularis might be acutely swollen, and may subsequently 
shrink due to loss of intermediate and marginal cells. Vasoconstriction and capillary loss 
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in the spiral ligament as well as a decreased strial blood flow has also been detected 
(29-31). These changes may transiently alter the EP, elevating auditory threshold shifts.  
 Noise insults caused by impulse noise, such as an explosion, can directly cause 
mechanical damage to the inner ear (32). The extreme impact of vibrations can forcefully 
cause the organ of Corti to detach from the basilar membrane, break the tympanic 
membrane or damage the middle ear ossicles. Furthermore, the rupture of the basilar 
and Reissner’s membranes may cause large ionic and osmotic changes that further 
accelerate sensory hair cell death (33).  
 
2.4 Noise-induced apoptosis and necrosis of hair cells 
Noise-induced cochlear pathologies cause both apoptotic and necrotic hair cell death. 
Apoptotic cell death is a programmed cell death pathway commonly characterized by 
condensed nuclei with activation of multiple cell death pathways that are primarily 
regulated by caspases. Caspase 8 and 9 are initiator caspases that are frequently 
cleaved in extrinsic apoptotic pathways mediated by death receptors such as Fas cell 
surface death receptor. Intrinsic apoptosis is primarily induced in response to 
intracellular stress such as calcium overload or DNA damage. Intrinsic apoptosis is 
associated with the formation of a pore on the outer mitochondrial membrane by the pro-
apoptotic Bcl-2 family mediators, such as Bax. The activation of Bax causes uncoupling 
of the mitochondrial membrane and mitochondrial membrane permeabilization, resulting 
in the release of mitochondrial proteins and apoptotic factors, such as endonuclease G 
and cytochrome C, into the cytosol (34).  Endonuclease G can translocate into the 
nucleus where it is able to mediate DNA fragmentation. On the other hand, cytochrome 
C initiates a cell death cascade that triggers the cleavage of caspase 9.  Both of the 
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extrinsic and intrinsic apoptotic pathways converge on caspase 3, the executioner 
caspase, involved in the final stages of apoptosis (35).  
The pathological feature of necrotic cell death is characterized by swollen nuclei 
(36). The necrotic cell death pathways are not well understood, although recent studies 
have proven that a regulated form, termed necroptosis, commonly occurs. In necrosis, 
damage to the cell membrane causes a disruption of cell homeostasis as an influx of 
fluid and extracellular ions enter the cell and eventually cause swelling and rupture.  
Moreover, the membranes of internal organelles are also compromised, releasing 
lysosomal enzymes that exacerbate the damage. In necroptosis, the receptor-interacting 
protein (RIP) kinases 1 and 3 mediate necrotic cell death via the stimulation of death 
receptors (37, 38). RIP1 can directly interact with the death domains of death receptors, 
resulting in its activation and the subsequent cleavage of caspase 8.  Additionally, RIP1 
can also be activated through its interaction with RIP3.  
Both apoptotic and necrotic cell death pathways have been detected in OHCs 
following noise exposure (39-41). Caspases 8, 9 and 3 have been expressed in OHCs 
with condensed nuclei after noise exposure (39, 42). Additionally, noise exposure 
caused the release of cytochrome C and the translocation of endonuclease G, which 
















 Cell shrinkage 
 Nuclear condensation 
and fragmentation 
 Intracellular stress (Ca
2+
, DNA damage) 
 Mitochondrial outer membrane 
permeabilization (Bax, Bak) 
 Cytochrome C release 
 Nuclear translocation of EndoG and AIF 
 Activation of caspase-9, -3 
Extrinsic 
Apoptosis 
 Cell shrinkage 
 Nuclear condensation 
and fragmentation 
 Death receptor signaling 
 Activation of caspase-8, -3 
Necroptosis 
 Cell swelling and 
vacuolization  
 Nuclear swelling 
 Death receptor signaling 
 RIP1/3 activation 
 Activation of caspase-8 
 
Table 1. Characteristics of cell death pathways. Apoptotic cells are primarily 
characterized by nuclear condensation and induced by intracellular stress (intrinsic) or 
death receptors (extrinsic), while necrotic nuclei are and may be initiated by membrane 
permeabilization (necrosis) or death receptor signaling (necroptosis). 
 
3. Mechanisms of noise-induced hearing loss 
3.1 Evidence for noise-induced ATP reduction 
Cochlear tissues use energy in the form of adenosine triphosphate (ATP) to maintain the 
steep ionic gradients across cell membranes. Energy reserves, as determined by levels 
of high energy phosphate, are primarily localized in the cells of the organ of Corti, 
followed by the stria vascularis, and lowest levels within the SGN, although the rate of 
energy metabolism is higher in the stria vascularis (45). Previous reports demonstrate 
the noise-induced cellular reduction of ATP levels in the cochlea associated with noise-
induced permanent hearing loss, but no change with temporary hearing loss (40, 46-48). 
In the cochlea, high intensity of noise exposure decreases capillary blood flow and 
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caused local vasoconstriction (49, 50). The resulting ischemia decreases ATP levels 
within the inner ear, including the lateral wall structures (46, 47, 51).  The maintenance 
of ATP levels via creatine, a compound that enhances cellular energy stores, attenuates 
temporary and permanent NIHL in guinea pigs, suggesting that conservation of ATP 
levels may prevent the initiation of subsequent pathological events such as free radical 
formation (52). Creatine kinase is abundant in the stria vascularis marginal cells, it is 
probable that the creatine treatment acts to maintain the endocochlear potential by 
supplying ATP for ionic pumps since the endocochlear potential is reduced by noise 
insults (53, 54). 
Additionally, extracellular ATP can serve as a second messenger within the 
cochlea. Extracellular ATP concentrations are increased in the endolymph fluid of the 
guinea pig cochlea after noise insults, probably due to the release of ATP from vesicles 
in the stria vascularis or gap junctional hemichannels of supporting cells (55-57). This 
increase in extracellular ATP levels is implicated in both the pathogenesis and mitigation 
of NIHL (58, 59). An exogenous delivery of ATP provides a protective response and 
accelerates recovery from temporary threshold shifts in a guinea pig model possibly 
through its effect in reducing the endocochlear potential to desensitize the sensory cell 
response to noise insults (60). Extracellular ATP can initiate a variety of pathological 
signaling pathways through the purinergic receptors in the inner ear including OHC 
electromotility and calcium signaling, which may ultimately alter cochlear sensitivity (57, 
61-63).  
 
3.2 Evidence for noise-induced ROS production 
The mitochondrial electron transport chain is implicated as a major source for reactive 
oxygen species (ROS) produced by cochlear tissues.  Due to the high energy demands 
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of the cochlea, and particularly the stria vascularis in the maintenance of endolymph 
ionic balance, ROS are often produced as a product of the mitochondrial metabolism. 
During oxidative respiration, 98% of molecular oxygen is used by mitochondria to 
generate ATP. Under normal physiological conditions, 1-2% of the molecular oxygen is 
reduced to free radicals such as superoxide which can be oxidized to less toxic 
hydrogen peroxide by mitochondrial superoxide dismutase (SOD). This level of ROS can 
dramatically increase under pathological conditions (64, 65).  
Increased ROS generation in cochlear tissues, including in OHCs, stria 
vascularis, and fluids, by traumatic noise exposure is well documented and persists for 
days after the exposure (66-71). Treatment with the superoxide generator paraquat 
induces a similar pattern of OHC death and permanent auditory threshold shifts as that 
induced by noise exposure, suggesting ROS as a cause for noise-induced cochlear 
pathology (72). The most intriguing evidence for the role of oxidative stress in NIHL is 
that treatment with a variety of antioxidants, such as Coenzyme Q, glutathione, D-
methionine, N-acetyl-cysteine, salicylate and trolox, reduces the extent of noise-induced 
auditory deficits (71, 73-77). In line with this notion, basal OHCs, which are more 
susceptible to noise damage, contain a lower level of the antioxidant glutathione 
compared with their more resistant apical counterparts (78). Defects in antioxidant 
genes, such as a single nucleotide polymorphism in the mitochondrial manganese-
superoxide dismutase gene in factor workers and glutathione peroxidase in mice 
increased susceptibility to noise-induced hearing loss (79-81).  
While the source for this elevated ROS is still unclear, theories speculate that 
free radicals are triggered by the effects of ischemia-reperfusion or the influx of free 
calcium on mitochondria via dysregulation of the calcium-regulated enzyme α-
ketoglutarate dehydrogenase within the Krebs cycle (82). Furthermore, targeting the 
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nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex, the major 
superoxide generator of the cell membrane, prior to noise exposure protects against hair 
cell death and the elevation of auditory threshold shifts by lowering the level of ROS 
generation (83). Supporting this concept, noise insults also induce the formation of the 
ROS by-product and vasoconstrictor 8-isoprostaglandin F(2alpha) in cochlear tissues 
and treatment with its antagonist block 8-isoprostaglandin F(2alpha)-induced reductions 
in cochlear blood flow (CBF) (50). The ischemia-reperfusion that results from a decrease 
in CBF may also contribute to increased oxidative stress.  
 
3.3 Evidence for noise-induced calcium influx 
Acoustic overstimulation has been shown to increase OHC cytoplasmic calcium 
concentration in guinea pig sensory cells (84-86).  Evidence has demonstrated a 
sustained 60% increase in calcium-dependent fluorescence in guinea pig OHCs 
accompanied by a decrease in cochlear microphonics immediately following exposure to 
extremely high levels of noise at 130 dB.  On the other hand, normal sound levels of 75 
and 88 dB did not alter intracellular calcium levels of cochlear sensory cells (85).  
Moreover, in addition to increased fluorescence of free calcium in isolated OHCs of the 
guinea pig cochlea, hearing loss and OHC death was also significantly increased 
following high levels of noise exposure at 110 dB (85).  
  The role of calcium influx and signaling in the pathogenesis of NIHL is 
emphasized by inner ear studies investigating the plasma membrane calcium-ATPase 
(PMCA), the channel by which calcium is extruded to maintain the low intracellular 
calcium concentration of hair cells and prevent calcium overload (87).  Mutant PMCA-
null mice displayed deafness while heterozygotes exhibited significant hearing loss (88).  
Furthermore, the activation of calcium-dependent enzymes such as calcineurin increase 
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in the dying OHCs of guinea pigs exposed to noise trauma.  Treatment with inhibitors of 
the calcium-dependent enzyme calcineurin, FK506 and cyclosporine A, reduce NIHL 
and hair cell death (89).   
  In addition to increased intracellular OHC calcium concentration, endolymph 
calcium levels increase by 50-fold in the noise-exposed guinea pig. This generates a 
high ionic concentration gradient that results in the entry of calcium into sensory cells 
through various channels, such as the VGCC and MET channels (90). At physiologic or 
resting membrane potential, VGCCs are normally closed.  These channels open when 
excitable sensory cells are depolarized, allowing calcium entry into the cell. Several 
VGCC subunits are in the auditory organ of the chinchilla, guinea pig, and murine 
cochlea (91-93).  The α1 subunit of VGCC is the pore forming component that is 
necessary for proper functioning of the channel.  In fact, its critical role in hearing 
function is highlighted by evidence showing that α1D-deficient mice are deaf (94, 95).  
Importantly, the VGCCα1 subunit is immunolocalized within IHCs and OHCs, but not 
supporting cells, of the chinchilla cochlea  (91). The basolateral localization of VGCCs 
allow for the concentration of calcium influx at the synaptic ribbon active zone. The 
calcium concentration at this nanodomain functions to trigger neurotransmitter release at 
the ribbon synapse. However, an overloading of calcium influx can also cause 
synaptopathy by stimulating the excessive release of glutamate neurotransmitters at the 
synapse. The resulting overactivation of glutamate receptors on the post-synaptic 
terminals can cause excitotoxicity and swelling of the nerve terminals, resulting  in 
functional deficits. 
VGCCs are composed of several channel types that vary in their physiological 
roles.  L-type and T-type VGCCs vary in their activation.  L-type channels are high 
voltage-activated channels that require stronger than ~30 mV depolarization to open.  
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On the other hand, T-type channels are low voltage-activated channels that require only 
small changes in the resting membrane potential (~10 mV) to open (93, 96).  L-type 
VGCCs are the predominant VGCC in IHCs and are also present in OHCs (97).  Several 
L-type channel blockers diltiazem, verapamil, nicardipine, and nimodipine reduce the 
auditory threshold shift and decrease hair cell loss in female ddY mice at 8 weeks of age 
(98).  Delivery of the L-type, high voltage-activated channel blocker diltiazem protects 
guinea pig OHCs from acute noise exposure (99).  Furthermore, diltiazem treatment 
reduces the calcium content of guinea pig IHCs and OHCs under normal conditions 
(100).  T-type channel blockers ethosuximide and trimethadione, delivered via drinking 
water, also protect against hearing loss and OHC death primarily in the basal turn of the 
C57BL/6 cochlea after noise exposure at 110 dB (101). Trimethadione protects against 
both TTS and PTS hearing loss and hair cell death, while ethosuximide significantly 
prevents only PTS (101). 
 
3.4 Interplay of calcium, ATP and ROS 
The previous sections review the three major metabolic events associated with NIHL:  
reduction of intracellular ATP levels, calcium influx and generation of ROS. However, a 
comprehensive mechanism of how these noise-induced metabolic stressors ultimately 
alter cell fate causing noise-induced cochlear pathologies is still unknown. It is likely that 
these changes in cellular energy, calcium and oxidative balance are interrelated in both 
normal and pathological cell function. 
 The relationship between these metabolic phenomena is particularly apparent in 
the mitochondrion. Under physiological conditions, calcium serves a beneficial function 
as a stimulus for ATP synthesis. Mitochondria serve as calcium sinks that rapidly uptake 
calcium via mitochondrial calcium uniporter (MCU) channels, providing buffering 
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capacity for cytosolic calcium overload. These channels are located within the inner 
mitochondrial membrane and transport calcium ions into the mitochondrial matrix 
through a process that is primarily driven by the negative charge of the mitochondrial 
membrane potential. This process is necessary for the stimulation of calcium-activated 
dehydrogenases located in the mitochondrial matrix:  pyruvate dehydrogenase, α-
ketoglutarate and isocitrate dehydrogenase. The sum of these activities enhances the 
aerobic respiration and the ATP output of the mitochondrion. The reduction of 
mitochondrial membrane potential in mitochondrial disease reduces the uptake of 
calcium into mitochondria and subsequent ATP production; treatment with a drug that 
restores mitochondrial matrix calcium content restores ATP production (102).  
 Alternatively, increases in matrix calcium content can trigger a pathological 
response. Calcium overloading of the mitochondrial matrix can reduce the mitochondrial 
membrane potential and subsequently reduce ATP production.  This may be caused by 
a sustained opening of the mitochondrial permeability transition pore (mPTP) which is 
associated with cell death pathways. In contrast, a lower mitochondrial calcium content 
increases protective cellular functions such as autophagy, probably through increased 
kinase activity of AMPK, rather than driving a pro-apoptotic response  (103). The 
physiological calcium stimulus typically changes into a pathological response when the 
cell is stressed due to accompanying insults which can include oxidative stress.  
Calcium-mediated events can also directly affect ROS. For example, calcium can 
stimulate electron flow from the Kreb cycle to increase aerobic respiration and its 
associated ROS by-products. Additionally, calcium can stimulate the production of nitric 
oxide via nitric oxide synthase in the cytosol which can subsequently act to inhibit 
complex I or IV of the electron transport chain, enhancing ROS production (104).  ROS 
can regulate calcium levels and mitochondrial activity. ROS can activate mitochondrial 
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uncoupling proteins to dissipate the mitochondrial membrane potential, which would 
probably be accompanied by reduced ATP output, reduced uptake of mitochondrial 
calcium and increased cytosolic calcium (105). On the other hand, ROS can also be 
regulated by mitochondrial activity, since mitochondrial uncouplers decrease ROS 
generation as well as ATP production (106, 107). This evidence highlights the 
multifaceted interactions among these three metabolic events (108). 
 The relationship between these metabolic stressors is further complicated by the 
often intertwining cross-talk and feedback loops that propagate the pathological 
stimulus. For example, the calcium or ROS-induced release of cytochrome C from the 
mPTP can disrupt the function of the inositol 1, 4, 5-triphosphate receptor (IP3R) on the 
endoplasmic reticulum, another calcium store. A high cytosolic calcium level inhibits the 
opening of this calcium to prevent ER calcium release under physiological conditions; 
however, the cytochrome C-induced dysfunction prevents this autoinhibition, 
propagating the calcium overload (109). Extracellular ATP release by the marginal cells 
of the stria vascularis can also regulate ER calcium release through the P2Y 
metabotropic G-protein coupled receptors (GPCRs). The P2Y GPCRs activate 
phospholipase C (PLC), an enzyme which cleaves membrane phospholipids, releasing 
IP3. IP3 then binds to IP3R in the ER, activating calcium release into the cytosol. 
Mitochondrial ROS also stimulate feedback loops that can cause mitochondrial 
dysfunction. ROS generation within the matrix via complex I is sensitive to the 
mitochondrial membrane potential and thus its dissipation can significantly reduce ROS 
levels (110). Since uncoupling can be stimulated by ROS, a resulting feedback loop may 
exist that further potentiates the dissipation of membrane potential. Meanwhile, it is likely 
that this mitochondrial dysfunction will be accompanied by a reduced ATP output and 
calcium uptake.  
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Finally, since ATP is necessary for many ion pumps within the many cellular 
membranes, any disruption of ATP levels will impact ionic balance across mitochondria, 
cytosol and endoplasmic reticulum. The exacerbation of ion transport across 
membranes will result in a disturbance in ion gradients that will worsen reduction in ATP 
levels and aggravate ROS generation as a consequence. Thus, the initial stimulus of 
intracellular calcium influx, ATP reduction or ROS generation can induce pathological 
responses through sustained propagation of these cyclical actions. Moreover, the 
complexities of these intertwining pathways challenge our understanding of the initiating 
pathological stimuli and the subsequent turn of events. 
 
4. Significance 
The investigation of NIHL can have a profound impact on public health as noise trauma 
is one of the most common causes of hearing loss in the adult population worldwide.  In 
addition to the detrimental auditory defects of noise on war veterans and industrial 
workers, NIHL also poses negative economic consequences of $242.4 million annually 
as NIHL has become one of the most common work-related disabilities (7). Since the 
underlying molecular mechanisms of NIHL and the clinical therapy for its prevention and 
treatment have not been established, detailed mechanisms of hair cell death in NIHL 
need to be elucidated in order to identify new targets for the development of a 














Male CBA/J mice at the age of 11 weeks, breeding pairs of CaMKKβ C57BL/6J 
heterozygous mice (B6.129X1-Camkk2tm1Tch/J; stock #014172), AMPKα1 C57BL/6 
knockout mice (Prkaa1tm1.1Sjm/J; stock #014141) and wild type of C57BL/6J were 
purchased from The Jackson Laboratory. All mice had free access to water and a 
regular mouse diet (Purina 5025, St. Louis, MO) and were kept at 22 ± 1 °C under a 
standard 12:12 hour light-dark cycle to acclimate for one week before the experiments. 
All experiments were conducted at the age of 12 weeks for male CBA/J mice. A younger 
age of seven weeks was used for CaMKKβ C57BL/6J knockout and littermates and 
AMPKα1 C57BL/6J knockout and wild type mice due to the ahl homozygous mutation on 
cadherin 23 which causes progressive age-related hearing loss in the C57BL/6J strain of 
mice. All research protocols were approved by the Institutional Animal Care & Use 
Committee at the Medical University of South Carolina (MUSC). Animal care was under 
the supervision of the Division of Laboratory Animal Resources at MUSC. 
 
Noise exposure 
CBA/J mice at 12 weeks of age were exposed to a broadband noise (BBN) with a 
frequency spectrum from 2–20 kHz for two hours at either 106 dB SPL to induce severe 
permanent threshold shifts that range from 50 – 65 dB at high frequencies or 98 dB SPL 
to induce moderate permanent threshold shifts (PTS) that range from 40 – 50 dB (71).  
All knockout and wild type C57B/6J mice at seven weeks of age were exposed to three 
different conditions of 94, 98 or 106 dB SPL BBN to induce PTS. Generally, four mice 
(one mouse per stainless steel wire cage) were placed in a sound exposure chamber 
and exposed at the same time. Age- and gender-matched control mice were kept within 
the same chamber and cages for two hours without noise exposure. The sound 
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exposure chamber was the same as we previously described (39, 40, 71). Briefly, it was 
fitted with a loudspeaker (model 2450H; JBL) driven by a power amplifier (model XLS 
202D; Crown Audio) fed from a CD player (model CD-200; Tascam TEAC American) 
which played BBN.  Audio CD sound files were created and equalized with audio editing 
software (Audition 3; Adobe System, Inc.). Sound levels were calibrated with a sound 
level meter (model 1200; Quest Technologies) at multiple locations within the chamber 
to ensure uniformity of the sound field among the four cages, and were measured before 
and after exposure to ensure stability.  
 
Auditory brainstem responses (ABR) 
Mice were anesthetized with an intra-peritoneal (IP) injection of xylazine (10 mg/kg) and 
ketamine (100 mg/kg), and then placed in a sound-isolated and electrically shielded 
booth (Acoustic Systems, Austin, TX). Body temperature was maintained near 37 °C 
with a heating pad. Acoustic stimuli were delivered monaurally to a Beyer earphone 
attached to a customized plastic speculum inserted into the ear canal. Sub-dermal 
electrodes were inserted at the vertex of the skull, under the left ear and under the right 
ear (ground). ABRs were measured at 8, 16, and 32 kHz. Tucker Davis Technology 
(TDT) System III hardware and SigGen/Biosig software were used to present the stimuli 
(15 ms duration tone bursts with 1 ms rise-fall time) and record the response. Up to 1200 
responses were averaged for each stimulus level. Thresholds were determined for each 
frequency by reducing the intensity in 10 dB increments and then in 5 dB steps near 
threshold until no organized responses were detected. Thresholds were estimated 
between the lowest stimulus level where a response was observed and the highest level 




Drug administration via intra-peritoneal (IP) route  
The pharmacological AMPK inhibitor compound C (Sigma #P5499) was dissolved in 
dimethyl sulfoxide (DMSO) as a stock solution (31.25 mg/mL) and stored at -20 °C. The 
stock solution was diluted in 0.9% saline immediately before being injected into animals. 
Each animal received a total of three IP injections at a dose of 20 mg/kg or 10 mg/kg per 
injection. The three IP injections were administered 24 hours before, two hours before, 
and immediately after noise exposure. The animals were euthanized one hour after 
noise exposure and temporal bones were removed to dissect the cochlea for 
immunofluorescence assays. The mice used for experiments to observe the progression 
of ABR thresholds received an additional IP injection 24 hours after noise exposure. 
 Verapamil was dissolved in 0.9% saline solution as a stock solution (0.01 g/mL) 
and stored at -20 ºC. The stock solution was diluted in saline immediately before being 
injected into animals. Each animal received a total of five IP injections of verapamil at a 
dose of 10 mg/kg per injection.  The five IP injections were administered 24 and 1 hour 
before, immediately after, 24 and 36 hours after noise exposure. The ABR thresholds 




Figure 5. Drug administration via intraperitoneal injection. The doses of Compound 
C and verapamil are illustrated. Injections of each drug were delivered prior to and after 
a 2 h noise exposure (pink square). The time course (hours) shown is relative to noise 
exposure and begins with time 0 at the start of the 2 h noise exposure.  Time points prior 
to noise exposure are noted with a negative sign (-).  
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Intra-tympanic delivery of siRNA  
siAMPKα1 (Invitrogen #s98535), siLKB1 (Invitrogen #s74497), siCaMKKβ (Invitrogen 
#n437808) or scrambled siRNA (siControl) (Invitrogen) was locally delivered via intra-
tympanic application, which allows the entry of siRNA specifically within sensory hair 
cells and minimal detection in other cochlear cell types (40, 111, 112). Briefly, after 
anesthesia, a retroauricular incision was made to approach the temporal bone. The otic 
bulla was identified ventral to the facial nerve and a shallow hole was made in the thin 
part of the otic bulla with a 30 G needle and enlarged with a dental drill to a diameter of 2 
mm to visualize the round window. A syringe was inserted into one end of a customized 
sterile Micro Medical tube. The other end of the tube was inserted into the hole just 
above the round window to slowly deliver 10 μL (0.3, 0.6 or 0.9 µg) of a single siRNA 
species via syringe. After the siRNA delivery, the hole was covered with surrounding 
muscle and glued with tissue adhesive. Lastly, the skin incision was closed with tissue 
adhesive and the mouse was kept in the surgical position for one hour. Seventy-two 
hours after siRNA delivery, the animals were exposed to noise or kept in silence in the 
noise chamber for two hours.  
  
Surface preparations and DAB staining of cochlear epithelia for hair cell counts 
The procedures for surface preparations and diaminobenzidine (DAB) staining of 
cochlear epithelia were followed as previously described (40). Briefly, the temporal 
bones were removed immediately following euthanasia and perfused through the 
cochlear scala media with a solution of 4% paraformaldehyde in phosphate buffered 
saline, pH 7.4 (PBS) and kept in this fixative overnight at 4 °C. The cochleae were then 
rinsed in PBS. The cochlea were decalcification in a 4% solution of sodium EDTA 
(adjusted with HCl to pH 7.4) and the solution was changed daily for three days and 
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maintained at 4 °C. Following decalcification, the cochleae were placed in 3% hydrogen 
peroxide for 2.5 hours to quench endogenous peroxidases. After incubation in 10% 
normal goat serum to block non-specific antibody binding overnight at 4 °C, the tissues 
were incubated with a primary antibody (rabbit polyclonal anti-myosin VII, Proteus 
Bioscience # 25-6790) at a 1:100 dilution for 4 days at 4 °C on a Nutator mixer, washed 
in PBS, and then incubated overnight at 4 °C with secondary antibody (biotinylated goat 
anti-rabbit) at a 1:100 dilution. The specimens were rinsed again and then incubated in 
ABC solution (Vector Laboratories # PK-4001) overnight. Following another washing, the 
cochleae were incubated in DAB for three hours, as necessary for sufficient staining 
intensity, followed by washing to stop the DAB reaction. Finally, the cochleae were 
micro-dissected under a microscope into apical, middle, and basal segments and 
mounted on slides with Fluoromount-G mounting medium. Images were taken with Zeiss 
AxioCam MRc5 camera with Axioplan 2 imaging software with a Zeiss microscope for 
hair cell counts.  Hair cells were counted from captured images using the 40× 
magnification lens on the Zeiss microscope. The lengths of the cochlear epithelia were 
measured and recorded in millimeters. Both OHCs and IHCs were counted from the 
apex to the base along the entire length of the mouse cochlear epithelium. Percentages 
of hair cell loss in each 0.5 mm length of epithelium were plotted as a function of the 
cochlear length as a cytocochleogram. 
 
Immunohistochemistry for cochlear paraffin sections 
Following decalcification with 4% EDTA, each cochlea was embedded in paraffin for 
sections. The 5 μm formalin fixed paraffin embedded (FFPE) sections were routinely 
deparaffinized in xylene and rehydrated in alcohol. The sections were incubated with 
target retrieval solution (Dako S2367) in a steamer (Oster CKSTSTMD5-W) for 10 
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minutes and then 3% hydrogen peroxide for 10 minutes and protein block (Dako x0909) 
for 20 minutes at room temperature. Primary antibody was incubated overnight in a 
humid chamber at 4 oC, followed by biotinylated secondary antibody (Vector, CA USA) 
for 30 minutes and ABC reagent (Vector, CA USA) for 30 minutes. Immunocomplexes of 
horseradish peroxidase were visualized by DAB (Dako, Glostrup, Denmark) reaction, 
and sections were counterstained with hematoxylin before mounting.  
 
Immunohistochemistry for cochlear surface preparations  
Following decalcification with 4% EDTA, each cochlea for immunocytochemistry of 
surface preparations was dissected under a microscope by removing the softened otic 
capsule, stria vascularis, Reissner’s membrane, and tectorial membrane. The remaining 
tissue, including the modiolus and cochlear sensory epithelium, was permeabilized in 
3% Triton X-100 solution for 30 minutes at room temperature. The specimens were 
washed three times with PBS and blocked with 10% goat serum for 30 minutes at room 
temperature, followed by incubation in darkness at 4 °C for 72 hours with primary 
antibodies: monoclonal rabbit anti-p-AMPKα (Thr 177) at 1:50 (Cell Signaling 
Technology #2535S), monoclonal rabbit anti-AMPKα1 at 1:50 (Abcam #ab32047), 
monoclonal rabbit anti-AMPKα2 at 1:100 (Abcam ab3760), monoclonal rabbit anti-LKB1 
at 1:100 (Cell Signaling Technology #13031), monoclonal rabbit anti-p-LKB1 at 1:50 
(Cell Signaling Technology #3482), monoclonal mouse anti-LYK5 (STRADα) at 1:100 
(Sigma-Aldrich SAB1402648), monoclonal rabbit anti-CtBP2 at 1:100 (BD Biosciences 
#612044), polyclonal rabbit anti-CaMKKβ at 1:100 (ThermoFisher #PA5-30399), 
monoclonal rabbit anti-CaMKI at 1:100 (abcam #ab68234), and polyclonal rabbit anti-
CaMKIV at 1:100 (ProteinTech #13263-1-AP). After washing three times, the tissues 
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were incubated with the Alexa Fluor 594 or 488-conjugated secondary antibody at a 
concentration of 1:200 at 4 °C overnight in darkness. After washing, specimens were 
incubated with Alexa Fluor 488 phalloidin at a concentration of 1:100 for 1 hour in 
darkness. After the final wash with PBS, the tissue was dissected in PBS by removing 
the modiolus. The epithelia were divided into three segments (apex, middle, and base). 
Specimens were mounted on slides with Fluoro-gel with Tris buffer (Electron Microscopy 
Sciences # 17985-10). Control incubations were processed without primary antibody 
treatments. Images were taken using a Zeiss or Lecia laser confocal microscope (Zeiss 
LSM 510 or Leica TCS SP5).   
 
Quantification of the immunolabeled signals from outer hair cells of surface 
preparations 
 
Immunolabeled signals of OHCs on surface preparations was quantified from original 
confocal images, each taken with a 63× magnification lens under identical conditions 
and equal parameter settings for laser gains and PMT gains, using ImageJ software 
(National Institutes of Health, Bethesda, MD). The cochleae from the different groups 
were fixed and stained simultaneously with identical solutions and processed in parallel. 
All of the surface preparations were counter-stained with Alexa Fluor 488 phalloidin 
(green) to label hair cell structure. The borders of each individual OHC were outlined 
with the circle tool based on the phalloidin staining. The immunofluorescence of the 
target proteins were measured in the upper basal region of cochlear surface 
preparations in 0.12 mm segments, each containing about 60 OHCs. The intensity of the 
background fluorescence was subtracted and average fluorescence per cell was 
calculated. The fluorescence was quantified by normalizing the ratio of average 
fluorescence of noise-exposed hair cells to the average fluorescence of the unexposed 
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hair cells. The overlap coefficient for LKB1 and STRADα in OHCs was determined using 
Zeiss Zen colocalization software. In these studies, there were no differences in the 
levels of p-AMPKα, LKB1, STRADα, p-CaMKI and p-CaMKIV molecules in OHCs of the 
apical and middle turns between ears of control mice and those harvested one hour after 
noise.  
 
Quantification of the immunolabeled ribbons from Z projections on surface 
preparations 
 
Immunofluorescence of CtBP2 on surface preparations was quantified from original 
confocal images, each taken with a 63× magnification lens under identical Z-stack 
conditions with 0.25 intervals and equal parameter settings for laser gains and PMT 
gains. Three Z-stack images each in 0.12 mm segments (containing about 16 IHCs) 
were captured at the 22 kHz region (3 mm from the apex) of cochlear surface 
preparations. The number of synaptic ribbons were counted using ImageJ software 
(National Institutes of Health, Bethesda, MD). Briefly, the background of the images was 
subtracted, the noise was despeckled and the threshold was set to isolate the 
immunolabeling of ribbon signals from IHCs. The image was converted to a binary file 
and the number of ribbon particles was counted using the 3D Object Counter. The binary 
file was converted to a 3D zy projection to measure ribbon dispersion (Fig. 6).  
 
Figure 6. 3D reconstruction of CtBP2-immunolabeled synaptic ribbons. (a) ImageJ 
software was used to subtract background noise and isolate ribbon signals and convert 
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to the 3D image. Dotted line:  representative outline of IHC. Scale bar = 5 μm. (b) The 
3D image was rotated along the x-axis to visualize a zy projection of the ribbons for 
measurement of dispersion. Red line:  representative line for measurement of dispersion 
in zy projection. 
 
Extraction of total cochlear protein  
Cochleae were rapidly removed and dissected in ice-cold PBS, pH 7.4, containing 
CompleteTM Mini EDTA-free protease inhibitor cocktail tablets (Roche Diagnostic GmbH 
# 11836170001). To extract total protein, tissues from the cochleae of a single mouse 
were homogenized in ice-cold RIPA lysis buffer containing RIPA lysis buffer (Sigma 
Aldrich #R0278) plus Phosphatase Inhibitor Cocktails II and III, and Roche protease 
inhibitor by using a glass/glass micro tissue grind pestle and vessel for 30 seconds. 
Tissue debris were removed by centrifugation at 10,000 × g at 4 °C for 10 minutes and 
the supernatants were retained as the total protein fractions. Protein concentrations 
were determined using the Bio-Rad Protein Assay dye reagent (Bio-Rad) with bovine 
serum albumin as a protein standard. Two cochleae from the same mouse were pooled 
for each sample. Unless otherwise specified, all chemicals and reagents used were 
purchased from Sigma Aldrich. 
 
Extraction of protein from formalin-fixed sensory epithelium  
Cochleae were rapidly removed and perfused with 4% paraformaldehyde through the 
cochlea scala media for two hours at room temperature (25 °C). The cochleae were then 
rinsed in PBS and decalcified in a 4% solution of sodium EDTA for three days at 4 °C, 
with the EDTA solution changed daily. Following decalcification, the dissected sensory 
epithelium from three cochleae were placed in 1.5 mL collection tubes with 100 μL of 
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extraction buffer EXB plus (Qiagen Qproteome FFPE Tissue kit #37623) supplemented 
with β-mercaptoethanol. Glass micro grinder pestles were used to grind the tissue for 
three minutes.  The tubes were sealed with a sealing clip and vortexed. The samples 
were incubated on ice for five minutes, followed by vortexing. The tubes were then 
incubated for 20 minutes at 100 °C on a heating block. After this incubation, the tubes 
were incubated for two hours at 80 °C with agitation at 750 rpm (eppendorf) and then 
allowed to cool at 4 °C for 1 minute. Finally, the samples were centrifuged at 14,000 x g 
at 4 °C for 15 minutes. The supernatant containing the extracted proteins were 
transferred to a new tube. Protein concentrations were determined using the Bio-Rad 
RC DC protein assay (Invitrogen #500-0119) with bovine serum albumin as a protein 
standard.  
 
Western blot analysis 
Protein samples (30 µg) were separated by SDS-PAGE. After electrophoresis, the 
proteins were transferred onto a nitrocellulose membrane (Pierce Rockford, IL) which 
was blocked with 5% nonfat dry milk in PBS-0.1% Tween 20 (PBS-T). The membranes 
were incubated with anti-p-AMPKα (1:1,000), anti-AMPKα1 (1:1000), anti-p-LKB1 
(1:1000), anti-LKB1 (1:1000), anti-CaMKKβ (1:1000), anti-CaMKI (1:1000), anti-CaMKIV 
(1:1000) or anti-GAPDH (Millipore # ABS16, 1:10,000) at 4 °C overnight, and then 
washed three times (10 minutes each) with PBS-T buffer. Membranes were incubated 
with an appropriate secondary antibody at a concentration of 1:2,500 for one hour. 
Following extensive washing of the membrane, the immunoreactive bands were 
visualized by SuperSignal® West Dura Extended Duration Substrate or Pierce® ECL 
Western Blotting Substrate (Thermo Scientific). X-ray films of Western blots were 
scanned and analyzed using ImageJ software. The band densities were first normalized 
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to background. Next, the probing protein/GAPDH ratio was calculated from the band 
densities run on the same gel. Finally, the difference in the ratio of the control and 
experimental bands was tested for statistical significance. 
 
Extraction of total cochlear RNA for qPCR  
Cochleae were rapidly removed and isolated in RNAlater (Invitrogen). Cochleae from a 
single mouse were placed in a 2 mL tube with 100 μL of RNAlater and immediately 
crushed with forceps. A 1 mL volume of TRIzol (Invitrogen) was added to each sample, 
followed by homogenization with an RNase-free Polytron tissue grinder (Kinematica). 
The samples were incubated for 5 minutes at room temperature prior to the addition of 
0.2 mL of chloroform and vigorous shaking. After 2-3 minutes of incubation, the samples 
were centrifuged at 12,000 × g at 4 °C for 15 minutes and the upper colorless aqueous 
phase was retained and transferred to Phase Lock Gel Heavy (Eppendorf) tubes. The 
0.2 mL of chloroform was added to each sample and followed by centrifugation at 
12,000 × g at 4 °C for 10 minutes. The upper aqueous phase was transferred to a fresh 
RNase-free tube for RNA precipitation with 1.5 μL of glycogen and 0.5 mL of 
isopropanol, followed by centrifugation at 12,000 × g at 4 °C for 10 minutes. The RNA 
pellet was washed in 75% ethanol and dissolved in DEPC water. RNA concentrations 
were determined using the Nanodrop spectrophotometer. Absolute copy numbers were 
analyzed using the QX100 Droplet Digital PCR System (Bio-Rad). Unless otherwise 
specified, all chemicals and reagents used were purchased from Sigma Aldrich.  
 
Statistical analysis 
Data were analyzed using SYSTAT and GraphPad software for Windows.  The group 
size (n) in vivo was determined by the variability of measurements and the magnitude of 
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the differences between groups. Based on our previous and current preliminary studies, 
we determined that six to eight animals per group provided sufficient statistical power (p 
< 0.05). Statistical methods used include one-way Analysis of Variance (ANOVA) with 
Tukey’s multiple comparisons, repeated-measures ANOVA with post-hoc testing, 
unpaired t-tests, and one-sample t-tests.  All tests were two-tailed and a p-value < 0.05 

















The survival of essentially all organisms depends on the dynamic control of energy 
metabolism during acute or prolonged exposure to various stress (113). Adenosine 
monophosphate-activated protein kinase (AMPK) is a cellular energy sensor that is able 
to detect and react to the fluctuations of the AMP:ATP ratio of the cell (114). This kinase 
serves as a key regulator of energy homeostasis that coordinates metabolic pathways 
with the energy demands of the cell by directing the cell to switch off energy consuming 
activities and turn on energy-generating pathways (113, 115, 116). In response to an 
increase in AMP levels, the AMPKγ subunit allosterically binds AMP, resulting in a 2-5 
fold increase in the activity of AMPK (117). In addition to this allosteric activation, the 
binding of AMP exposes the threonine 172 (T172) residue on the catalytic α-subunit to 
reversible phosphorylation by upstream kinases such as liver kinase B1 (LKB1). 
Moreover, the conformational change of the kinase domain induced by AMP binding 
protects AMPK from the activity of phosphatases (118).  This combined activation via 
allosteric and phosphorylation mechanisms causes a 1000-fold increase in the kinase 
activity of AMPK, allowing high sensitivity in response to small changes in the 
intracellular energy status (119).  
The regulation of cellular energy homeostasis by AMPK contributes to its role in 
the determinations of cell fate as energy is necessary for cellular survival. Initially, the 
activation of AMPK was considered an adaptive response to cellular stress; however, 
there are diverse outcomes of AMPK activity on cell death and survival. In neuronal 
cells, in particular, AMPK has a neuroprotective effect to glutamate excitotoxicity by 
elevating Glucose Transporter 3 trafficking in response to a decrease in cellular ATP 
levels (120). On the other hand, the sustained activation of AMPK has a hazardous 
42 
 
effect on the cell in some models of cellular stress, including ischemia-reperfusion, 
hypoxia and stroke (121, 122). The prolonged elevation of p-AMPK triggers the chronic 
activation of the c-Jun N-terminal kinase (JNK), upregulation of pro-apoptotic Bim and 
subsequent apoptosis in neuronal and pancreatic cells (120, 123, 124). AMPK is also 
able to inhibit JNK activity in neuronal cells, suggesting that the regulation of cell fate by 
AMPK is complex and may depend on the cell type and insult (120, 125, 126). Despite 
the central functions of AMPK in the regulation of cell death and survival, no studies thus 
far have elucidated the role of AMPK in noise-exposed sensory hair cells.  
The small molecule Compound C (dorsomorphin) is a selective, potent, cell-
permeable AMPK inhibitor through its ATP-competitive function (127). Many studies 
demonstrate the effectiveness of Compound C in inhibiting the activation of AMPK and 
its downstream activities. For example, treatment with Compound C in vivo protects 
against stroke-induced cerebral damage. Validating its pharmacological target, this 
neuroprotection is absent in AMPKα2-knockout mice (122).  
Total AMPKα1 mRNA and protein expression is localized in murine cochlear 
tissue, with predominant expression in OHCs (128). The phosphorylation of AMPKα is 
detectable in OHCs and cochlear tissues, particularly after exposure to noise insults (40, 
47). Furthermore, ROS-dependent robust activation of AMPKα is detected in the stria 
vascularis in a transgenic mouse mitochondrial disease model that exhibits hearing loss 
(129). In this chapter, our investigation focuses on the activation of AMPK by noise 
exposure in the inner ear using the mouse model that our lab has characterized in detail. 
We also explore the role of AMPK in the pathogenesis of NIHL using the 





Noise conditions for temporary and permanent threshold shifts. 
Based on our previously characterized parameters for CBA/ J mice, noise conditions for 
TTS (92 dB SPL) without OHC loss, PTS (98 dB SPL) with only OHC loss, and severe 
PTS (106 dB SPL) with both OHC and IHC loss were used (40, 71). Exposure of CBA/J 
mice at 12 weeks of age to broadband noise (BBN, 2-20 kHz) for 2 h at 92 dB SPL did 
not alter threshold shifts at 2 weeks after the exposure. On the other hand, a 98-dB 
exposure increased threshold shifts by 30, 50, and 55 dB at 8, 16, and 32 kHz, and a 
106-dB exposure resulted in even larger threshold shifts at all three measured 
frequencies (Fig. 8a). Two weeks after noise exposure, the 98-dB exposure resulted in 
partial OHC loss beginning around 3.5 mm from the apex and increasing toward the 
base, while IHCs remained intact (Fig. 8c, d). The 106-dB noise exposure resulted in 
loss of both OHCs and IHCs (Fig. 7). OHC loss began around 2.5 mm from the apex 
(Fig. 8b) and IHC loss began around 4.5 mm from the apex (Fig. 8c), following a base-
to-apex gradient with increased severity towards the base. The amount of OHC loss 
induced by 106 dB SPL was significantly higher than by 98 dB SPL. Age-matched sham-
exposed control mice presented no elevation of auditory thresholds or hair cell loss 2 
weeks after exposure. In agreement with the literature, synaptic ribbon number was also 
reduced in an intensity-dependent fashion (19, 130). Two weeks after a 106-dB noise 
exposure, the activity of auditory nerve fibers were decreased as determined by reduced 
ABR wave I amplitudes at 8, 16 and 32 kHz (Fig. 9). Additionally, 1 h after a 98-dB noise 





AMPKα is activated in basal outer hair cells by noise in an intensity-dependent 
manner.  
Using the above conditions, we first assessed the activation of the cellular metabolic 
sensor AMPK after noise exposure at 92, 98 and 106 dB SPL in OHCs of surface 
preparations. The expression of phosphorylated AMPKα (p-AMPKα) at threonine 172 in 
OHCs 1 h after 92-dB exposure was similar to age-matched controls without the 
exposure; however, immunolabeling for p-AMPKα in basal OHCs was increased by 60% 
after 98-dB and 230% after 106-dB exposure compared to controls (Fig. 11a, a’). Since 
changes in AMPKα phosphorylation were only detected under the PTS noise conditions, 
PTS noise exposures were used for the rest of the study. To evaluate the localization of 
this increased p-AMPKa in three key regions of the cochlea, the organ of Corti, spiral 
ganglion and stria vascularis, p-AMPK was immunolabeled in cochlear sections. In the 
control animal, immunolabeling for p-AMPKa in OHCs (arrow heads) and IHCs (arrow) 
was weak. One hour after 98-dB noise exposure, the expression of p-AMPKα was 
increased in IHCs and OHCs, but was only marginally increased and remained relatively 
weak within the SGNs and the stria vascularis (Fig. 11c). Western blot using formalin-
fixed tissues of the sensory epithelium detected a single band for p-AMPKα at 63 kDa, 
indicating the specificity of the antibody, although the band density was not altered with 
noise exposure (Fig. 11b). Since noise increased the activation of AMPKα, we also 
examined the expression of total AMPKα in cochlear cell types. In the control animal, 
immunolabeling for AMPKα1 was primarily localized to supporting cells, such as Deiters’ 
and pillar cells of the organ of Corti. One hour after 98-dB noise exposure, the 
immunolabeled AMPKα1 was increased in OHCs, IHCs and pillar cells in the organ of 
Corti, SGNs, the stria vascularis, including marginal and basal cells, and fibrocytes in the 
spiral ligament (Fig. 12a). Likewise, AMPKα2 immunolabeling was also increased in the 
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nuclei and cytosol of IHCs, OHCs, supporting cells, SGNs, the stria vascularis, and 
fibrocytes (Fig. 12b) 
 
Inhibition of AMPKα1 by pretreatment with AMPKα1 siRNA or pharmacological 
inhibitor compound C protected against noise-induced outer hair cell loss and 
permanent hearing loss. 
 
To determine the contribution of AMPKα to NIHL, AMPKα1 siRNA (siAMPKα1) was 
used. First, three concentrations (0.3, 0.6 and 0.9 µg) of siAMPKa1 were tested in 
preliminary in vivo experiments; 0.6 µg was selected for use in this study due to 
efficiency of siRNA entry into hair cells. As described in Chapter 2, the intratympanic 
delivery of siRNA resulted in the localization of siRNA specifically within OHCs and 
minor detection in other cochlear cell types. Surface preparations revealed a 20% 
reduction in AMPKα1 levels specifically within OHCs 72 h after treatment with 0.6 µg of 
siAMPKα1, compared to OHCs of mice that received scrambled siRNA (siControl) 
treatment. We then assessed if silencing AMPKα1 could diminish 98-dB noise-elevated 
p-AMPKα in OHCs. Pretreatment with siAMPKα1 reduced 30% of noise-elevated p-
AMPKα in OHCs (Fig. 13a, a’). Furthermore, pretreatment with siAMPKα1 prevented 
noise-induced OHC loss to baseline levels at 3 – 3.5 mm and significantly reduced OHC 
loss by over 55% at 4 – 5.5 mm distances from the apex of the sensory epithelium two 
weeks after the 98-dB exposure (Fig. 13d). Consequently, auditory threshold shifts of the 
siAMPKα1-treated group recovered to near baseline levels at 8 kHz and were attenuated 
from 50 to 10 dB at 16 and 32 kHz two weeks after 98-dB exposure (Fig. 13b). In 
addition, the siAMPKα1 pretreatment significantly reduced auditory threshold shifts by 30 
dB at 8 kHz and 20 dB at 16 and 32 kHz after exposure to 106-dB noise (Fig. 13c).   
 Since silencing AMPKα1 protected against noise-induced hair cell loss and NIHL, 
next, the effects of compound C, a selective ATP-competitive inhibitor of AMPK were 
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examined on noise-induced OHC death and hearing loss. Based on the literature, we 
tested two concentrations (10 and 20 mg/kg) in adult CBA/J mice (131). Our preliminary 
results indicated that mice receiving five doses of either concentration have normal 
bodyweights and hearing thresholds. The fur of treated mice also appeared as shiny as 
that of control mice and the mice displayed no overt signs of illness. Treatment with 
either concentration of compound C significantly reduced the auditory threshold shifts at 
8, 16 and 32 kHz two weeks after a 98-dB exposure in a dose-dependent fashion (Fig. 
13e).  Since the higher dose (20 mg/kg) of compound C elicited greater protection, OHC 
loss was examined in animals treated with this concentration. OHC loss remained lower 
than 10% throughout the basal region of the cochlea of compound C-treated mice two 
weeks after 98-dB exposure, in contrast to 40%, 90% and 100% OHC loss which 
occurred at 4, 5 and 5.5 mm from the apex in the vehicle (DMSO)-treated group (Fig. 
13g). Furthermore, treatment with compound C also reduced OHC loss by 50-20% at 4 – 
5.5 mm from the apex (Fig. 13h) and attenuated 106-dB noise-induced auditory 
threshold shifts by 30, 15 and 20 dB at 8, 16 and 32 kHz 2 weeks after the  exposure 
(Fig. 13f). However, treatment with compound C did not alter 106-dB noise-induced IHC 
loss (Fig. 13i). 
 
Inhibition of AMPKα1 via AMPKα1 siRNA or Compound C prevented noise-
induced loss of inner hair cell synaptic ribbons and decline of wave I amplitudes. 
 
In order to determine if blockade of AMPKa1 activation by siRNA or compound C can 
attenuate noise-induced loss of IHC synaptic connections, ribbons were counted one 
hour after, or ABR wave I amplitude was measured two weeks after noise exposure. 
Exposure to 98-dB noise significantly reduced synaptic ribbon counts by 50% one hour 
after the exposure, but the loss recovered to a level comparable to that of unexposed 
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controls 14 days later (Fig. 15a). Due to the significant recovery at 14 days after 
expsoures, the protection of synaptic ribbons was only examined after the 106 dB noise 
exposure. The 106-dB noise exposure decreased CtBP2-labeled synaptic ribbons on 
IHCs of surface preparations at 22 kHz (corresponding to a location 3 mm from the 
apex) by 70% one hour after the exposure compared to unexposed controls. 
Pretreatment with siAMPKα1 prevented loss of synaptic ribbons by 50% (Fig. 14a, b). 
Additionally, noise exposure caused a wide dispersion of synaptic ribbons along the IHC 
longitudinal axis, which was prevented with siAMPKα1 pretreatment (Fig. 14c). Although 
106-dB noise exposure induced synaptic ribbon loss, this loss was also partially 
recovered by 14 days after the exposure, but remained significantly lower than 
unexposed controls (Fig. 15b). Pretreatment with siAMPKα1 still significantly protected 
against the synaptic ribbon loss at 5, 8, 22 and 32 kHz, at a timepoint 14 days after the 
exposure  (Fig. 15c). ABR wave I amplitudes were examined 14 days after exposures at 
8 kHz (1 mm from apex) and 16 kHz (2.4 mm from apex) in order to avoid regions of hair 
cell loss (132). Fourteen days after exposure to 106 dB noise, the wave I amplitudes 
were significantly decreased at sound intensities of 70 – 100 dB at 8 and 16 kHz, 
compared to baseline controls. At 8 kHz, pretreatment with siAMPKα1 elevated the 
amplitude at 100 dB by greater than 3-fold (Fig. 15d). The decline of wave I amplitudes 
was also prevented at 16 kHz at 100 dB (Fig. 15e). Furthermore, treatment with 
compound C reduced the noise-induced loss of synaptic ribbons per IHC by 50% one 
hour after 106-dB noise exposure (Fig. 14d, e) and increased wave I amplitudes by 2-
fold at 8 kHz at intensities of 90 dB and 100 dB SPL compared to noise-exposed groups 








Noise-induced hearing loss was exacerbated in AMPKα1-KO mice, but not outer 
hair cell and synaptic ribbon loss. 
 
To explore the pathological consequences of AMPK activation in NIHL, AMPKα1-
knockout (AMPKα1-KO) mice were used (128). The knockout of AMPKα1 resulted in an 
80% reduction of p-AMPKα compared to WT littermates 1 hour after a 98-dB noise 
exposure (Fig. 16e). Despite the knockout of the α1 isoform, AMPKa1-KO mice had 
normal baseline auditory thresholds. Permanent threshold shifts were induced by 94, 98 
and 106 dB SPL noise exposures as determined 2 weeks after the exposure. The 94-dB 
noise exposure induced permanent threshold shifts of 30 dB at 16 and 32 kHz in both 
AMPKα1-KO and –WT mice 14 days after the exposure (Fig. 16a). Exposures to noise 
at both 98 and 106 dB SPL resulted in higher auditory threshold shifts for AMPKα1-KO 
mice at 32 kHz compared to WT mice under the same conditions (Fig 16b, c). The 32 
kHz threshold shifts of AMPKα1-KO mice were increased against AMPKα1-WT mice by 
30 to 45 dB and 60 to 70 dB 14 days after 98 and 106 dB exposures, respectively. 
Despite the threshold shifts, OHC loss was not altered in the cochlea of AMPKα1-KO 
mice compared to WT mice 2 weeks after 98 dB exposure (Fig. 16d). Furthermore, the 
number of synaptic ribbons at the middle turn (2.5 – 3.5 mm from the apex) did not differ 
between AMPKα1-KO and –WT mice 1 h after a 106 dB exposure, even though the 
noise exposure decreased CtBP2-labeled synaptic ribbons of WT mice by 50% 






Figure 7. Noise exposure caused a base-to-apex gradient of outer hair cell loss. 
Representative images of DAB-stained myosin VIIa immunolabeled hair cells document 
that OHC losses increase as a function of distance from the apex 14 days after noise 




Figure 8. Noise exposure induced 
permanent hearing loss and hair cell loss in 
adult CBA/J mice. (a) 98 and 106 dB SPL 
noise exposure induced significant auditory 
threshold shifts at 8, 16, and 32 kHz as 
detected 14 days after the exposures. n = 25. 
(b) Quantification of OHC loss 14 days after 
the exposures confirmed significant OHC loss 
with 106 dB SPL versus 98 dB SPL. 98 dB:  n 
= 7; 106 dB:  n = 3. (c) 106 dB SPL noise 
results in IHC losses in the basal turn. n = 5. 
Data are presented as means + SD. */# p < 









Figure 9. Noise exposure reduced the summed activity of auditory nerve fibers. (a, 
b, c) 106 dB SPL noise reduced the wave I amplitude at 8 kHz (a) at sound intensities of 
100, 90 and 90 dB SPL, at 16 kHz (b) at sound intensities of 90, 80, 70 and 60 dB SPL, 
and at 32 kHz (c) at 100, 90, 80 and 70 dB SPL, 14 days after the exposure. Data (a, b, 





Figure 10. Noise exposure caused swelling of spiral ganglion neurons. Sections of 
the adult CBA/J mouse inner ear showed swelling of spiral ganglion neurons 1 h after 98 
dB noise exposure. The swelling of noise-exposed spiral ganglion neurons is displayed 
by the non-stained (white) regions. The nuclei of the SGNs are labeled blue by 
hematoxylin and the cytosplasm can be viewed as pink by the eosin stain. 





Figure 11. Noise exposure increased p-AMPKα in basal outer and inner hair cells 
intensity-dependent manner. 
(a) The p-AMPKα (red) immunolabeling was stronger in basal OHCs with phalloidin 
staining (green) 1 h after exposure to 98 and 106 dB noises than unexposed controls. 
(a’) Immunolabeling of p-AMPKα in basal OHCs was significantly increased in a noise 
intensity-dependent fashion. Control: n = 4; 98 dB: n = 3, 106 dB: n = 4. (b) Western blot 
using sensory epithelium tissues displayed no difference in band densities of p-AMPKα 
(60 kDa) 1 h after 98 and 106 dB exposures compared to controls. GAPDH served as 
the loading control. n = 4. (c) Sections of the adult CBA/J mouse inner ear revealed 
increased DAB-stained immunolabeling of p-AMPKα (brown) in IHCs (arrow) OHCs 
54 
 
(arrowheads) of the organ of Corti, but no obvious changes were detected in spiral 
ganglion neurons and stria vascularis 1 h after 98 dB noise exposure. Representative 
images (a, c) were taken from the basal turn, scale bar = 10 µm. Data (a’, b) are 






Figure 12. Noise exposure increased total AMPKα1 and 2 in the organ of Corti. (a, 
b) Sections of the normal adult CBA/J mouse inner ear revealed increase in  DAB-
stained immunolabeling of total AMPKα1 (a) or AMPKα2 (b) (brown) in the organ of 
Corti, including in OHCs, IHCs, inner and outer pillar cells, spiral ganglion neurons, 
marginal and basal cells of stria vascularis, and fibrocytes of spiral ligament 1 h after 98 
dB noise exposure. AMPKα1 was mainly localized in cytosol, while AMPKα2 was 
predominantly localized in the nuclei. Representative images were taken from the basal 







Figure 13. Inhibition of AMPKα1 by siRNA and compound C protected against 
noise-induced hearing loss and outer hair cell loss. (a) Treatment with siAMPKα1 
decreased noise-induced immunolabeled AMPKα1 (red) in OHCs (labeled with 
phalloidin staining in green) compared to siControl treatment 1 h after 98-dB exposure. . 
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Representative images were taken from the basal turn, scale bar = 10 µm. (a’) 
Quantification of AMPKα1 in OHCs confirmed a significant decrease. n = 3. (b, c) 
siAMPKα1 pretreatment reduced 98 and 106 dB noise-induced permanent threshold 
shifts. 98 dB: n = 18; 98 dB + siControl: n = 8; 98 dB + siAMPKα1: n = 7; 106 dB: n = 6; 
106 dB + siControl: n = 3; 106 dB + siAMPKα1: n = 4. (d) Noise-induced (98 dB) OHC 
loss was reduced by siAMPKα1 pretreatment. n = 3. (e) Compound C treatment reduced 
98 dB noise-induced permanent threshold shifts in a dose-dependent fashion. 98 dB + 
DMSO: n = 20; 98 dB + CC 10 mg/kg: n = 4; 98 dB + CC 20 mg/kg: n = 6. (f) Compound 
C (20 mg/kg) treatment reduced 106 dB noise-induced permanent threshold shifts. n = 6. 
(g) Compound C (20 mg/kg) treatment decreased 98 dB noise-induced OHC loss. 98 dB 
+ DMSO: n = 7; 98 dB + CC 20 mg/kg: n = 6. (h) Compound C (20 mg/kg) treatment 
decreased the extent of 106 dB noise-induced OHC loss. 106 dB + DMSO: n = 3; 106 
dB + CC 20 mg/kg: n = 9. (i) Treament with compound C (20 mg/kg) did not alter 106 dB 
noise-induced IHC losses. n = 4. (j) Representative image displays DAB-stained myosin 
VIIa immunolabeling of sensory hair cells in the basal region of the control CBA/J 
mouse. Data (a’, b, c, d, e, f, g, h, i) are presented as means + SD, 14 days after the 





Figure 14. Inhibition of AMPK attenuated noise-induced inner hair cell synaptic 
ribbon loss at 22 kHz one hour after 106-dB noise exposure. (a) Noise-induced  loss 
of immunolabeled CtBP2 (red) in IHCs was prevented by pretreatment with siAMPKα1.  
(a’) Quantification of CtBP2 immunolabeled ribbon particles in IHCs confirmed that 
noise-induced reduction of ribbons was partially prevented with siAMPKα1 pretreatment. 
n = 4. (b) Noise-induced dispersion of CtBP2 immunolabeled ribbon particles along the 
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IHC y-axis returned to baseline levels with siAMPKα1 pretreatment. n = 4. (c) 
Compound C (20 mg/kg) treatment prevented the noise-induced loss of CtBP2 (red) 
immunolableled synaptic ribbons in IHCs. (c’) Quantification of CtBP2 immunolabeled 
ribbon particles in IHCs confirmed significant increases with compound C (20 mg/kg) 
treatment. n = 4. Representative images (a, c) were taken from the 22 kHz region, n = 4, 
scale bar = 10 µm. Dashed circles represent the outline of IHC nuclei.  Data (a’, b, c’) 





Figure 15. Inhibition of AMPK protected noise-induced synaptopathy and noise-
declined auditory nerve activity 14 days after 106-dB exposure. (a) CtBP2 
immunolabeled ribbon particles in IHCs at 22 kHz were significantly decreased 1 d after 
98-dB noise exposure, but slowly recovered by 14 days after the exposure. n = 3. (b) 
CtBP2 immunolabeled ribbon particles in IHCs at 22 kHz were significantly decreased 1 
h after 106 dB noise exposure, but the loss partially recovered by 14 d after the 
exposure. n = 10. (c) The noise-induced loss of CtBP2 immunolabeled ribbon particles in 
IHCs were significantly reduced 14 days after 106 dB noise exposure. Pretreatment with 
siAMPKα1 increased the number of synaptic ribbon particles at 5, 8, 22 and 32 kHz 
regions of the sensory epithelium. Control:  n = 4, 106 dB: n = 5, 106 dB + siControl: n = 
5; 106 dB + siAMPKα1: n = 5. (d) Wave I amplitudes were reduced by 106 dB noise 
exposure at sound intensities of 70 – 100 dB at 8 kHz. Pretreatment with siAMPKα1 
elevated the wave I amplitude at sound intensities of 90 and 100 dB SPL. Control:  n = 
10; 106 dB + siControl:  n = 8; 106 dB + siAMPKα1:  n = 4. (e) The reduction of wave I 
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amplitude by 106 dB noise was decreased by pretreatment with siAMPKα1 at sound 
intensities of 90 and 100 dB SPL at 16 kHz. Control:  n = 10; 106 dB + siControl:  n = 6; 
106 dB + siAMPKα1:  n = 4.  (f) The decrease of wave I amplitudes by 106 dB noise was 
reduced by compound C (20 mg/kg) treatment at sound intensities of 90 and 100 dB 
SPL at 8 kHz. Control:  n = 10; 106 dB + DMSO:  n = 14; 106 dB + CC 20 mg/kg:  n = 4. 
Data are presented as means + SD,  *** p < 0.001, ** p < 0.01, * p < 0.05. For Data (c, d, 






Figure 16. AMPKα1-KO mice exacerbated noise-induced hearing loss. (a) The 94 
dB SPL noise-induced permanent threshold shifts remained unchanged between 
AMPKα1-KO and –WT mice 14 days after the exposure. n = 3. (b) The 98 dB SPL 
noise-induced threshold shifts were increased at 32 kHz in AMPKα1-KO mice compared 
to WT counterparts as determined 14 days after the exposure. n = 5.  (c) The 106 dB 
SPL noise-induced threshold shifts were increased at 32 kHz in AMPKα1-KO mice as 
determined 14 days after the exposure. n = 8. (d) Noise-induced (98 dB) OHC loss was 
not altered by AMPKα1-KO. n = 6. (e) The levels of p-AMPKα protein were reduced in 
sensory epithelium tissues of AMPKα1-KO mice compared to WT counterparts exposed 
to 98 dB SPL, but remained unchanged between unexposed AMPKα1-KO and –WT 





Figure 17. Noise-induced inner hair cell synaptic ribbon loss was not altered by 
AMPKα1-KO. (a) The CtBP2-immunolabeled synaptic ribbons (red) in IHCs were 
reduced by 50% at 22.6 kHz 1 h after exposure to noise at 106 dB compared to 
unexposed cochlea. AMPKα1-KO did not alter the synaptic ribbon number compared to 
WT mice under exposed or unexposed conditions. (b) CtBP2 immunolabeled ribbon 
particles in IHCs were decreased 1 h after 106 dB noise exposure, but remained 
unchanged by AMPKα1-KO mice. AMPKα1-WT:  n = 3; 106 dB + AMPKα1-WT:  n = 4; 








Our results demonstrate for the first time that noise-induced phosphorylation of AMPKα 
in sensory hair cells mediates NIHL by increasing losses of synaptic ribbons and OHCs.  
Accordingly, agents that inhibit the activation of AMPK attenuated the loss of synaptic 
ribbons and OHC, and subsequently NIHL. The noise-intensity dependent increase of p-
AMPKα1 is in line with our previous reports (39, 40) and provides support for the 
concept of AMPK activation inducing hair cell death and NIHL. Additionally, total 
AMPKα1 and AMPKα2 increase with noise exposure and are predominantly localized in 
OHCs and IHCs as well as supporting cells such as Deiters and pillar cells, SGNs and 
stria vascularis. Noise-induced increases in total AMPKα1 and α2 may  provide sufficient 
levels of kinase for phosphorylation; however, it is not clear if such an increase is due to 
overexpression of the AMPKα gene or a decrease in protein degradation. An earlier 
report detected expression of AMPKα1 mRNA only in OHCs, but not IHCs (128), 
suggesting that noise-induced elevation of AMPKα1 in IHCs may not be related with 
gene expression. AMPKα1 was primarily localized in the cytosol, while AMPKα2 was 
localized in both the cytosol and nuclei. This isoform specific subcellular localization 
implies potential alterations in function. Since AMPKα2 is found localized in the nuclei, it 
is possible that this isoform is able to directly phosphorylate transcription factors and 
alter gene expression, while the α1 isoform may have less of an impact on gene 
expression and more of an effect in short term changes, such as the alteration of protein 
activity. 
Our evidence further supports the notion that AMPK activation leads to cell 
death. Since similar functional protection was achieved by both pharmacological 
inhibition and genetic silencing of AMPKα, we can conclude that treatment with siAMPK 
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or Compound C provides protection against noise-induced stimuli through its inhibition of 
AMPK.. It is surprising that pretreatment with siAMPKα1 reduces 98-dB thresholds shifts 
by 80% at 16 and 32 kHz with only  20% reduction of AMPKα1 and 30% reduction of 
noise elevated p-AMPKα levels detected in OHCs. This indicates that a specific partial 
inhibition of AMPKα1 in OHCs is sufficient for prevention of noise-induced outer hair cell 
loss and NIHL. Additionally, the activation of AMPK may alter multiple cellular targets 
that result in an augmented effect (116). It is aslo logical that treatment with compound C 
provides greater protection against noise-induced OHC losses compared to siAMPKα1 
pretreatment, which only targets the α1 isoform. Still, Compound C and siAMPKα1 
treatment does not reduce 106 dB noise-induced IHC losses, highlighting the severe 
damaging effect of the noise intensity-dependent activation of AMPK and the potential 
influence of multiple cell death pathways that may circumvent AMPK activation. For 
example, we previously described the modulation of noise-induced OHC apoptosis and 
necrosis by caspases and RIP-kinases, respectively. Inhibition of either pathway shifts 
the prevalence of OHC death to the alternative pathway (39), supporting the concept 
that multiple targets are necessary to comprehensively alter cell fate, especially for the 
severe damage. 
Our results are the first to implicate the activation of AMPK as a key initial 
mediator affecting synaptic ribbons and functional deficits. Inhibition of AMPK either via 
siAMPKα1 or Compound C reduces the extent of 106 dB noise-induced IHC synaptic 
ribbon loss one hour and 14 days after exposures and protects against the decline of 
wave I amplitudes associated with IHC synaptic density (19). The protection of synaptic 
ribbons may contribute to the protection of auditory thresholds at 8 kHz without 
corresponding loss of OHCs and IHCs (132, 133). Additionally, noise-induced synaptic 
ribbon dispersion is in line with Liberman’s study (130). Our results demonstrate that 
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such dispersion is also prevented by inhibition of AMPK by siRNA. This spatial disruption 
may have significant functional implications since functional synapses require the 
juxtaposition of pre-synaptic ribbons against post-synaptic terminals of auditory nerve 
fibers. Although the post-synaptic terminals were not detected in this study, it is likely 
that this synaptic ribbon dispersion is also associated with an increase in the number of 
“orphan” ribbons and post-synaptic terminals that are non-functional. Additionally, both 
98 and 106 dB exposures result in IHC synaptic ribbon loss that partially recovers over 
time, suggesting that noise-induced synaptopathy is reversible at least to some extent 
with the moderate noise damage. This contrasts with a previous report which showed no 
significant recovery between 24 hours and 14 days post-exposure (130). This 
discrepency may due to the variability of mouse stain. All of this evidence suggests that 
AMPK may be a target for prevention of noise-induced synaptopathy. 
Although pretreatment with siAMPKα1 or the pharmacological inhibitor 
compound C attenuates noise-induced losses of synaptic ribbons and OHCs and NIHL 
in CBA/J mice, AMPKα1-KO C57B6/J mice exacerbated NIHL at both 98 and 106 dB 
SPL, but not at noise conditions (90 - 94 dB SPL) that induces temporary or mild 
threshold shifts (less than 30 dB). This is in line with previous reports showing 
impairment of auditory threshold recovery after exposure to noise that causes temporary 
threshold shifts in AMPKα1-KO mice compared to –WT mice (128). These differences in 
lack of protection against NIHL in C57BL/6 and the excellent protection elicited by siRNA 
and compound C are probably related to strain-dependent changes. The AMPKα1-KO 
mice are on a C57BL/6 background and are thus not comparable to the CBA/J strain 
used for the siRNA and compound C studies. The C57BL/6 strain is characterized by an 
early onset age-related hearing loss that can develop as early as 1 – 6 months of age. 
This phenotype is caused by the presence of a homozygous recessive ahl mutation of 
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cadherin 23, which results in a splice variant that alters the stability and formation of 
stereocilia tip links necessary for mechanotransduction. To avoid the accelerated age-
related hearing loss that is associated with this strain, the experiments with the C57BL/6 
mice were conducted at a younger age of seven weeks, as opposed to three months of 
age for CBA/J mice. This modified noise model results in threshold shifts of 35 and 30 
dB at 16 and 32 kHz two weeks after a 98-dB noise exposure, contrasting with the 50 dB 
threshold shifts induced in CBA/J mice at three months of age. Age-matched 
comparisons of responses to noise exposures between the two strains were not made; 
therefore, we cannot comment on the noise susceptibilities between the C57BL/6 versus 
CBA/J mice with our noise conditions. However, other groups demonstrate that C57BL/6 
mice are more susceptible to NIHL compared to age-matched CBA/J at older ages of 
five to seven months due to the increased auditory degeneration associated with the 
accelerated age-related hearing loss of the C57BL/6 strain (134). Still, it is clear that the 
seven-week old C57BL/6 model used in this study induces a lower level of hearing loss 
compared to the three-month old CBA/J model. This was also accompanied by lower 
levels of hair cell losses.  
The inconsistencies between the siRNA, compound C and knockout studies also 
point to the intrinsic differences between the two methods of inhibition, in which siRNA 
silencing transiently inhibits the expression of a gene, while a knockout eliminates gene 
function for the animal’s entire lifespan. This fundamental difference is significant as it 
can affect the outcome of the gene knockdown or knockout. For example, the outcome 
of prolonged versus acute exposure to AMPK inhibition is different. A partial reduction of 
AMPK, modeled by silencing and pharmacological inhibition, may prevent the noise-
induced imbalance of AMPKα1 signaling, whereas abolishment of cellular AMPK by 
knockout of AMPKα1 alters other molecular events as well.  Since AMPK is traditionally 
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considered a protective enzyme that maintains cellular energy levels, we speculate that 
noise insults initially trigger a protective response which may convert into a pathological 
response with a hyper-elevated activation of AMPK. In line with this hypothesis, the 
knockout of AMPKα1 would eliminate all functions, including initial protective responses 
of AMPK, which may contribute to the deterioration of auditory sensitivity.  The efficiency 
of our protection strategies support this premise, with Compound C, a drug that targets 
both AMPKα isoforms acutely, being the most effective, followed by AMPKα1 siRNA, 
which targets the α1 isoform acutely and finally no protection elicited by the elimination 
of the α1 isoform in AMPKα1-KO mice.  
Despite the worsening of hearing function, the knockout of AMPKα1 does not 
alter noise-induced losses of OHCs and synaptic ribbons. In fact, noise-induced OHC 
loss is minimal at less than 10% loss, even at the very basal regions of the cochlea, 
implying that sensory hair cell deficits may play a minor role in the pathology induced by 
AMPKα1-KO mice and suggesting alteration of other molecular events, such as the 
abundance of BK channels in OHCs, in exacerbating NIHL (128). Alternatively, we 
speculate that the absence of protection by AMPKα1-KO mice may be caused by an 
overcompensation of the other AMPKα2 isoform. Since compound C is not specific for a 
particular AMPKα isoform, this overcompensation effect could be tested by 
pharmacological treatment of AMPKα1-KO mice. If our hypothesis is true, treatment with 
compound C should protect against NIHL in AMPKα1-KO mice due to its ability to 
decrease AMPKα2 activity. Furthermore, the separate isoforms may also differ in 
subcellular localization, targets and/or sensitivity to AMP, thus altering the response of 
AMPKα1-KO mice to noise insults. Sections show AMPKα1 predominantly localized in 
the cytosol of the cells of the cochlea, while the AMPKα2 isoform is found in both the 
nucleus and cytoplasm. This difference in distribution implies potential alterations in 
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function. Since AMPKα2 is found localized in the nuclei, it is possible that this isoform is 
able to directly phosphorylate transcription factors and alter gene expression, while the 
α1 isoform may have less of an impact on gene expression and more of an effect in 
short term changes, such as the alteration of short term protein activity.  
In agreement with the literature, AMPKα1 and 2 is also localized in the exposed 
stria vascularis, mainly in the marginal cells and basal cells, where p-AMPKα has been 
strongly detected post noise exposure in previous studies (47). The marginal cells of the 
stria vascularis have high energy requirements due to the abundant expression of 
sodium-potassium-ATPase (Na+-K+-ATPase) (135). To drive the active transport of ions 
across the membranes, these cells contain a large number of mitochondria to generate 
the necessary ATP (136). A transient cochlear ischemia inhibits the expression of Na+-
K+-ATPase and connexin 26, a marker for gap junctions through which K+ ions are 
cycled, and subsequently reduces the endocochlear potential (137).  
AMPKα1 and α2 are also strongly increased within the SGNs, which is 
accompanied by swelling of the neuronal bodies. This is in line with reports in the 
literature which demonstrate the swelling of afferent ribbon synapses, followed by 
degeneration of SGNs at later times. Pathological cellular swelling is commonly 
associated with an unregulated flux of cations, such as Na+, due to the failure of 
extrusion mechanisms that require ATP. Along with this influx of cations, anions are also 
driven into the cell, which subsequently drives the influx of water, causing the cell body 
to swell. The primary extrusion mechanism to maintain a cation balance in neuronal cells 
is Na+-K+-ATPase. Due to the energy-dependence of the extrusion pump, a depletion of 
ATP in spiral ganglion neurons would reduce the active transport of cations out of the 
cells and result in cellular swelling. Especially under noise-induced excitotoxic 
conditions, high levels of glutamate released at the ribbon synapses activate N-methyl-
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D-aspartate (NMDA) receptors which trigger the opening of non-selective cation 
channels. The survival of the SGNs depends upon ATP to maintain the homeostatic 
balance of the ATP-dependent extrusion pumps and the influx of non-selective cations 
(138).  
This evidence points to the stria vascularis, spiral ligament and spiral ganglion 
neurons as potential sites for AMPK-mediated pathology that we have not yet 
investigated since energy metabolism plays a critical role in the recycling of ions for the 
endolymph as well as the ionic balance of SGNs after excitotoxic injury. Overall, the 
results from this chapter point out a novel target for future development of drugs to 














Liver kinase B1 (LKB1) is an upstream serine/threonine kinase of AMPK which 
phosphorylates the enzyme under low energy levels (139). LKB1 activity is regulated by 
the adaptor protein Ste20 Related Adaptor (STRAD) and the scaffolding protein Mouse 
Protein 25 (MO25), which exist in a 1:1:1 intracellular ratio (140).  STRAD is a 
pseudokinase which allosterically binds the kinase domain of LKB1, while MO25 
stabilizes the LKB1 activation loop by interacting with both LKB1 and STRAD. This 
leaves the active site of LKB1 accessible, which is required for its kinase activity. The 
formation of a stable heterotrimeric LKB1/STRAD/MO25 complex translocates LKB1 
from the nuclei to the cytosol, where it exerts its serine/threonine kinase activity on 
AMPK, when bound by AMP (141) (Fig. 18). A specific mechanism for the regulation of 
the activation and inactivation of this heterotrimeric complex is yet unknown. The C-
terminal region of LKB1 contains several post-translational phosphorylation sites, 
including Serine 428 (S428). The phosphorylation of LKB1 at this site increased the 
phosphorylation of AMPK, while its mutation abolished AMPK activation (142). 
Moreover, the phosphorylation at S428 has been implicated as an important 
nucleotranslocation signal, for LKB1 to be actively exported out of the nucleus (142, 
143). In addition to AMPK, LKB1 directly phosphorylates a family of 14 various AMPK-
related kinases, such as the microtubule affinity regulating kinases (MARKs) (144). 
Currently, no research in the field has examined LKB1 in the inner ear or its role 
in NIHL or other inner ear disorders. In this chapter, the localization of LKB1 was 
examined and its role in the pathogenesis or NIHL and the noise-induced activation of 




Figure 18. LKB1 activates AMPK. Inactive LKB1 is present in the nucleus and 
becomes active when bound by its pseudokinase STRADα and adaptor protein MO25. 
The stable, active LKB1-STRAD-MO25 complex can receive a phosphorylating 
nucelotranslocation signal, which allows it be exported to the cytosol where LKB1 
phosphorylates AMPK on threonine 172 of the α-subunit, in the presence of AMP 






Noise exposure increased the phosphorylation of LKB1 in the organ of Corti. 
Since liver kinase B1 (LKB1) serves as the primary upstream kinase of AMPK, we 
examined the phosphorylation of LKB1 (p-LKB1) levels in the cochlea in response to 
noise insults. Immunoblots of total cochlear homogenates showed a single band for p-
LKB1 at the molecular weight of 54 kDa, which was robustly increased 1 h after the 
exposure (Fig. 19c). No change was detected in total LKB1 levels (Fig. 19d). Increased 
immunolabeling for p-LKB1 was localized to the nuclei and cytosol of the organ of Corti, 
mainly in the OHCs, IHCs, Deiters and pillar cells 1 h following the exposure (Fig. 19a). 
The increased immunolabeling for p-LKB1 in OHC cytosol was quantified on surface 
preparations, which showed a greater than 2-fold increase in high-frequency OHCs 1 h 
after the 98 dB exposure compared with controls (Fig. 19b).  No increases were 
detected in low-frequency OHCs. Furthermore, the p-LKB1 was also increased in the 
spiral ganglion neurons, the basal cells of the stria vascularis and the fibrocytes of the 
spiral ligament after the exposure (Fig. 19a).  
 
Noise exposure increased the colocalization of LKB1-STRADα in outer hair cells.  
In addition to the phosphoration of LKB1 at serine 428, the activty of LKB1 can be 
assessed by colocalization of LKB1 and STRADα in OHCs since LKB1 is allosterically 
activated by binding to the psuedokinase STRADα. Immunolabeling for total LKB1 and 
total STRADα in OHCs was increased by over 2-fold and almost 4-fold, respectively, 1 h 
after 98-dB noise exposure compared to controls (Fig. 20a). The overlap coefficient for 
LKB1-STRADα colocalization in OHCs was quantified and displayed a 2-fold increase in 
1 h after noise exposure (Fig. 20b).  
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Pretreatment with LKB1 siRNA reduced noise-induced p-LKB1 in outer hair cells, 
noise-induced outer hair cells loss and auditory threshold shifts. 
 
Since noise exposure resulted in activation of LKB1 in cochlear tissue, we evaluated the 
role of LKB1 in NIHL using siRNA silencing techniques. First, pretreatment with 0.6 µg 
siLKB1 resulted in a 20% reduction of total LKB1 specifically within OHCs and also 
reduced the phosphorylation of LKB1 caused by 98-dB noise exposure by 25%, 
compared to scrambled siRNA (siControl) treated groups (Fig. 21a). The siLKB1 
pretreatment prevented the extent of noise-induced OHC loss to baseline levels at 3.5 – 
4 mm and significantly reduced OHC loss by 50% at 4.5 – 5 mm from the apex (Fig. 
21c). This correlated with the reduction of noise-induced auditory threshold shifts from 
15 dB to baseline levels at 8 kHz and from 40-50 dB to 5 dB at both 16 and 32 kHz two 
weeks after the exposure (Fig. 21b).  
 
Pretreatment with LKB1 siRNA attenuated noise-induced losses of inner hair cell 
synaptic ribbons and ABR wave I amplitudes. 
To determine if inhibition of LKB1 activation by siRNA can attenuate noise-induced loss 
of IHC synaptic ribbons, ribbon particles were counted 1 h after, or wave I amplitude was 
measured 2 weeks after 106 dB noise exposure. For comparison with the protection of 
synaptic ribbons by inhibition of AMPK, the 106 dB noise condition was used. Noise 
exposure decreased CtBP2-labeled IHC synaptic ribbons from the 22 kHz region 
(corresponding to 3 mm from the apex) by 70% compared to unexposed controls. 
Pretreatment of siLKB1 prevented noise-induced synaptic ribbon loss. The ribbon count 
increased from 5 to 8 ribbons per IHC (Fig. 21a, b). ABR wave I amplitudes were 
examined at 8 (1 mm from apex) and 16 kHz (2.4 mm from apex) to avoid regions where 
hair cell loss occurred (132). Pretreatment with siLKB1 recovered the noise-reduced 
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ABR wave I amplitude at 70 and 80 dB at 8 kHz to baseline levels, and elevated the 
wave I amplitudes by at least 3-fold at 16 kHz (Fig. 22c, d).  
 
Silencing LKB1 reduced the noise-induced activation of AMPK in basal outer hair 
cells. 
 
To examine whether noise-induced phosphorylation of AMPKα1 is mediated by LKB1, 
CBA/J mice were pretreated with siLKB1 72 h prior to noise exposure at 98 dB SPL. 
Pretreatment with siLKB1 significantly reduced the 98 dB noise-induced immunolabeling 





Figure 19. Noise exposure increased p-LKB1 in the organ of Corti, spiral ganglion 
neurons and spiral ligament. (a) Cochlear sections showed increased DAB-stained 
immunolabeling of p-LKB1 (brown) in the cytosol and nuclei of OHCs, IHCs, supporting 
cells, spiral ganglion neurons, basal cells of the stria vascularis and fibrocytes of the 
spiral ligament 1 h after 98-dB noise exposure compared to unexposed controls. 
Representative images were taken from the basal turn, scale bar = 10 µm, n = 5. (b) 
Quantification of p-LKB1 immunolabeling in OHCs of surface preparations show 
increases 1 h after the exposure. n = 4. (c) Western blot using total cochlear 
homogenates showed increased p-LKB1 1 h after the exposure compared to controls. 
GAPDH served as the sample loading control. n = 5. (d) The levels of total LKB1 were 
not changed with noise exposure by Western analysis. n = 3. Data (b, c, d) are 





Figure 20. Noise exposure increased LKB1-STRADα colocalization in outer hair 
cells. (a) The LKB1 (red) and STRADα (blue) colocalization was stronger in OHCs 
(green) 1 h after 98 dB SPL exposure. (b) Quantification of LKB1 and STRADα overlap 
coefficient in OHCs displayed a significant increase after the noise exposure. n = 3. Data 






Figure 21. Inhibition of LKB1 reduced noise-induced p-LKB1 in outer hair cells, 
loss of outer hair cell loss and ABR threshold shifts. (a) Pretreatment with siLKB1 
significantly decreased p-LKB1 immunolabeling in OHCs 1 h after the exposure. n = 5. 
(b) Pretreatment with siLKB1 reduced 98 dB noise-induced threshold shifts at 16 and 32 
kHz 14 days after the exposure. n = 5. (c) Quantitative analysis of OHCs revealed 
significant protection with siLKB1 pretreatment 14 d after the exposure. 98 dB + 
siControl: n = 12; 98 dB + siLKB1: n = 3. Data (a, b, c) are presented as means + SD, 





Figure 22. Inhibition of LKB1 partially prevented noise-induced inner hair cell 
synaptic ribbon loss at 22 kHz and decline of ABR wave I amplitude. (a) 
Pretreatment with siLKB1 increased the CtBP2 (red) immunolableled synaptic ribbons in 
IHCs 1 h after 106-dB noise exposure. Representative images were taken from the 
middle turn, n = 4, scale bar = 10 µm. Dashed circles show the outline of IHC nuclei. (b) 
CtBP2 immunolabeled ribbon particles in IHCs increased with siLKB1 pretreatment. n = 
4. (c, d) Pretreatment with siLKB1 recovered wave I amplitudes to baseline levels at 8 
kHz (c) and attenuated the decline of wave I amplitudes at 16 kHz (d). Control:  n = 10; 
106 dB + siControl:  n = 11; 106 dB + siLKB1:  n = 6; *:  106 dB + siControl vs 106 dB + 
siLKB1. Data (b, c, d) are presented as means + SD, *** p < 0.001, ** p < 0.01, * p < 




Figure 23. Noise-induced phosphorylation of AMPKα is reduced in outer hair cells 
of siLKB1 pretreatment mice. (a) Pretreatment with siLKB1 decreased p-AMPKα 
immunolabeling (red) in OHCs (labeled with phalloidin staining green) of CBA/J mice 1 h 
after 98-dB exposure. n = 3. (a’) Quantification of p-AMPKα immunolabeling in OHCs 






Our results are in agreement with the concept that LKB1 is an AMPK kinase. This 
conclusion is supported by data demonstrating that inhibition of LKB1 by siRNA reduced 
98 dB noise-induced auditory thresholds to near baseline levels similar to that achieved 
by pretreatment with siAMPKα1 or Compound C. Despite the excellent functional 
protection, the reduction of OHC and synaptic ribbon loss by pretreatment with siLKB1 
was not as great compared to that achieved by siAMPKα1 or Compound C. This implies 
the involvement of other players that may be affecting noise-induced auditory thresholds 
which may include the disruption of hair cell stereocilia stiffness or structure or an 
alteration in the neurotransmission of SGNs, since robust p-LKB1 levels were detected 
in all  cell types in the cochlea. The pretreatment of siLKB1 reduced p-AMPKα by about 
20%, similar to the 30% reduction detected with siAMPKα1 treatment, making a strong 
case for the direct phosphorylation of AMPK by LKB1 following noise exposure.  
The activation of LKB1 in the organ of Corti, including in the nuclei and cytosol of 
OHCs, IHCs, supporting cells, SGNs, stria vascularis and total cochlear tissue 
homogenates, after noise exposure indicates reduction of intracellular ATP levels in the 
cochlea, which is in line with our previous publication (40). The discrepancy between 
increased levels of p-LKB1 in Deiters cells and other supporting cell types with minimal 
AMPK activation after noise exposure may be owed to an effect of intrinsic differences in 
homeostatic defense systems against metabolic stress as supporting cells are resistant 
to inner ear insults, while sensory hair cells are vulnerable (145-147). Alternatively, it is 
plausible that off-target effects of LKB1 activity play divergent roles in cochlear sensory 
cells versus supporting cells since LKB1 is known to phosphorylate a total of 14 AMPK-
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related kinases including the microtubule affinity regulating kinases (MARKs), which are 
involved in cellular polarity and cytoskeleton regulation (144, 148).  
The detailed molecular mechanisms by which LKB1 is activated and transported 
to the cytosol remain unclear. The phosphorylation of LKB1 was localized partially within 
the cytosol and nuclei of sensory and supporting cell types in the organ of Corti, SGNs 
and stria vascularis (143). This high level of nuclear and cytosolic localization suggests 
that serine 428 (Ser428) phosphorylation is a necessary site for LKB1 translocation. The 
activation of LKB1 after noise exposure is further reinforced by the increased 
colocalization of LKB1 with the pseudokinase STRADα within OHCs (142, 149-151). 
In summary, we provide evidence that noise increased the phosphorylation of 
LKB1 and its colocalization with the pseudokinase STRAD in sensory hair cells and 
supporting cells. LKB1 mediated the loss of IHC synaptic ribbons, OHCs and auditory 
function after noise exposure. Silencing of LKB1 reduced the loss of OHCs and synaptic 
ribbons and decreased auditory threshold shifts. Similar to the protection by siAMPKα1, 
we detected a disproportional effect of LKB1 siRNA treatment, which reduced LKB1 by 
20% in OHCs specifically, and reduced the functional deficits by over 80%. This 
suggests that the activity of LKB1 also likely alters multiple cellular targets, one of which 
is AMPK, which may then also induce several of its own signaling pathways, causing this 
amplified functional protection. Still, inhibition of AMPK (Chapter 3) was more effective in 
protecting against noise-induced auditory deficits than the inhibition of LKB1, which was 
not able to completely diminish AMPK phosphorylation. This suggests that the inhibition 
of the LKB1 pathway is ony one mechanism to abolish AMPK activity and alternative 







CHAPTER FIVE:  AMPK ACTIVATION BY CAMKKβ VIA 






As described in Chapter 1, the disruption of calcium homeostasis by calcium 
influx has been involved in NIHL. As the level of intracellular calcium increases, calcium-
binding messenger protein calmodulin (CaM) acts as a calcium buffer and sensor, 
binding free calcium via its two calcium-binding sites. This calcium/CaM complex 
changes the conformation of CaM, allowing it to interact with a variety of proteins, 
including calcium/calmodulin-dependent protein kinases (CaMKs), a group of 
serine/threonine protein kinases that are activated following increases in intracellular 
calcium levels (152).  In particular, calcium/CaM can stimulate downstream calcium 
signaling via CaMKK. 
CaMKK consists of 2 isoforms, CaMKKα and CaMKKβ.  CaMKKβ is primarily 
expressed in the brain and neuronal tissues and plays a role in signaling neuronal 
processes (153).  CaMKKβ is an upstream kinase for calcium-calmodulin kinase (CaMK) 
I and IV. These two kinases require the formation of calcium/CaM complexes and 
phosphorylation of CaMKK to become functional. The binding of calcium/CaM exposes a 
loop on CaMKI and CaMKIV that can be phosphorylated by CaMKK (154).  Following its 
phosphorylation, CaMKIV can translocate to the nucleus to stimulate downstream 
targets, such as the transcription factor cAMPK response element-binding protein 
(CREB). CaMKI primarily promotes cytosolic signaling pathways that regulate the 
cytoskeleton and neuronal plasticity through the phosphorylation of mitogen-activated 
protein (MAP) kinases. In addition, CaMKKβ can phosphorylate AMP-activated protein 
kinase (AMPK), a cellular energy sensor that regulates the energy balance of the cell 
(155) (refer to Chapter 3). The CaMKKβ-AMPK pathway requires calcium/CaM binding 
in addition to phosphorylation by CaMKKβ (155) (Fig. 24).  
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Calcium overload and disruption of intracellular calcium homeostasis can trigger 
apoptotic or necrotic cell death through the activation of calcium dependent enzymes, 
such as calcineurin, caspases, calpain proteases and endonucleases (156, 157).  These 
calcium-dependent enzymes can cleave cell survival proteins such as Bcl-2 or 
dephosphorylate pro-apoptotic proteins such as BAD, promoting cell death (158, 159).  
Moreover, CaM levels are elevated after noise trauma in the guinea pig cochlea, 
increasing the activation of downstream calcium signaling pathways (85).  On the other 
hand, the inhibition of calcium signaling pathways prevented apoptosis in a variety of cell 
types.  Treatment with W7, an inhibitor of CaM, prevented apoptosis in the presence of 
apoptotic bioprobes (160).  Treatment with the calcium chelator, BAPTA-AM blocked 
apoptosis by buffering intracellular calcium levels.  Additionally, calcium influx can also 
cause synaptopathy by stimulating the excessive release of glutamate neurotransmitters 
at the synapse. The resulting overactivation of glutamate receptors on the post-synaptic 
terminals can cause excitotoxicity and swelling of the nerve terminals, resulting  in 
functional deficits. 
In this chapter, the expression of CaMKKβ in the inner ear was characterized in 
detail. The role of noise-induced calcium influx and subsequent CaMKKβ signaling in the 
pathogenesis of NIHL and the noise-induced activation of AMPK was examined using 
CaMKKβ siRNA silencing and CaMKKβ-knockout mice. In addition, we also used the 
pharmacological inhibitor of calcium channels Verapamil. Verapamil is a non-selective, 
L-type, high-voltage activated calcium channel blocker (161). It is a FDA-approved drug 
commonly used for its antihypertensive and antianginal effects due to its potent 
vasodilation activity (162).  The drug plasma concentrations peak at 1-2 hours after 
administration and it has a half-life of 2.8 – 7.4 h, but the half-life increases even further 
after repetitive dosing.  Verapamil has the ability to transverse the blood brain barrier 
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(163). Generally, a low dosage is necessary to elicit protective responses in several 
tissue types, including the murine cochlea (98, 164-167).  Specifically, in the murine 
noise model, of four L-type voltage-gated calcium channel (VGCC) blockers that 
decreased the ABR threshold shift, verapamil had a significantly lower dose (98). 
 
 
Figure 24. CaMKK signaling. Calcium binding protein calmodulin (dark yellow) is 
activated by the binding of 4 calcium ions (green). The active complex activates 
CaMKKs (red), which, when active, phosphorylate downstream kinases including CaMKI 






Treatment with the calcium channel blocker verapamil reduced noise-induced 
hearing loss and outer hair cell death. 
 
We first examined the contribution of calcium influx into OHCs via L-type, high voltage-
gated calcium channels (VGCCs) to NIHL by administering IP injections of the calcium 
channel blocker verapamil and assessing the protection against NIHL. Two weeks after 
98 dB SPL BBN exposure, measurement of auditory thresholds displayed a reduction of 
noise-induced PTS in the verapamil-treated group compared to vehicle-treated groups at 
16 and 32 kHz (Fig 25a). After 106 dB SPL, verapamil treatment reduced thresholds 
shifts at 8 kHz, but was unable to alleviate NIHL at 16 and 32 kHz (Fig. 25b).  
Next, OHC losses were quantified along the entire length of the cochlear 
epithelium 14 days after 98 dB SPL BBN exposure. The OHC loss was decreased in the 
verapamil-treated group compared to the vehicle-treated group (Fig. 25c, d). The loss of 
OHCs with verapamil treatment began at 3.5 mm instead of at 3.0 mm from the apex as 
detected with vehicle treatment. OHC loss was reduced from 40% to 5% at 4 mm, and 
80% to 40% at 4.5 mm from the apex with verapamil treatment. In contrast, treatment of 
verapamil did not alter the number of IHC synaptic ribbons at the 22 kHz region of the 
sensory epithelium (3 mm from the apex) which were reduced 1 h after 106 dB noise 
exposure (Fig. 26a, a’).  
 
Noise increased CaMKKβ activity in basal outer hair cells and other cochlear cell 
types. 
 
Since CaMKKβ is a central kinase in calcium signaling cascades, the level of CaMKKβ 
was examined after noise exposure at 98 dB SPL. In the unexposed animal, CaMKKβ 
was weakly localized in all cell types in the organ of Corti, spiral ganglion neurons, and 
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stria vascularis, but strongly expressed in the fibrocytes of the spiral ligament. One hour 
after the noise exposure, CaMKKβ was increased in the organ of Corti, including in 
IHCs, OHCs, pillar and Deiters cells, spiral ganglion neurons, stria vascularis, including 
marginal and basal cells, and spiral ligament (Fig. 27a). Western blot of total cochlear 
homogenates detected a single band for CaMKKβ at 55 kDa without alteration after 
noise exposure (Fig. 27b).  
We then detected CaMKKβ activity by assessing the phosphorylation of its 
downstream targets, CaMKI (p-CaMKI) at threonine 177 and CaMKIV (p-CaMKIV) at 
threonine 196. To quantify the intensity of p-CaMKI and p-CaMKIV staining specifically 
within OHCs, surface preparations were immunolabeled. Surface preparations showed 
punctate increases in the immunolabeling for p-CaMKI (Fig. 28a, a’) by 73% and p-
CaMKIV (Fig. 28b, b’) by 95% across basal OHCs 1 h after 98 dB exposure compared to 
unexposed controls. Severe 106 dB noise exposure resulted in changes in the 
immunolabeling pattern of p-CaMKI from broad punctate increases across basal OHCs 
to robust increases in the cuticular plate of select basal OHCs 1 h after the exposure 
(Fig. 28c). The p-CaMKI-labeled OHCs followed a gradient in which the lower basal 
region (5 mm from the apex) of the epithelium displayed the majority of p-CaMKI positive 
OHCs and only a few were present in the upper basal region (4 mm from the apex) (Fig. 
28c’). Immunoblots of total cochlear homogenates detected a single band for p-CaMKI 
and p-CaMKIV at molecular weights of 45 and 60 kDa without alteration after noise 
exposure (Fig. 28d, e).  
 
Pretreatment with CaMKKβ siRNA reduced noise-induced CaMKKβ activity and 
protected against noise-induced loss of outer hair cells and hearing function. 
 
In order to determine the contribution of CaMKKβ to NIHL, the effects of CaMKKβ siRNA 
(siCaMKKβ) pretreatment on noise-induced loss of hair cells and NIHL was examined. 
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Seventy-two hours after the delivery of 0.6 µg siCaMKKβ, CaMKKβ immunolabeling was 
significantly reduced by 47% in basal OHCs (Fig. 29a, a’). Immunolabeling of its 
downstream target p-CaMKI was not altered in unexposed cochlea, but the 98-dB noise-
induced increases in p-CaMKI were reduced by 20% with siCaMKKβ pretreatment. 
Finally, pretreatment with siCaMKKβ attenuated 98-dB noise-induced threshold shifts by 
35 and 30 dB at 16 and 32 kHz measured at two weeks after the exposure (Fig. 29b). 
Noise-induced OHC loss was also completely prevented at 3.5 – 4 mm and reduced by 
50 – 40% at 4.5 - 5.5 mm from the apex (Fig. 29c, d).  
 
Noise induced hearing loss and outer hair cell loss were reduced in CaMKKβ-KO 
mice.  
 
Finally, CaMKKβ-knockout (CaMKKβ-KO) mice were utilized to explore the pathological 
function of CaMKKβ in NIHL. We first detected an 84% decrease in CaMKKβ mRNA 
copy number within the cochlea of CaMKKβ-KO mice compared to their WT 
counterparts (Fig. 30e). No differences were detected for the CaMKKα isoform (Fig. 30f). 
Despite these changes in CaMKKβ expression, CaMKKβ-WT, -KO and heterozygous 
mice showed similar baseline auditory function (Fig. 30g) 
We then assessed the effect of noise of 92, 94 and 98 dB SPL in CaMKKβ-WT, -
KO and –heterozygous mice. The 92 and 94 dB SPL noise exposures induced an 
average of 30 dB PTS only at 32 kHz that remained unchanged between CaMKKβ-KO 
and –WT littermates 2 weeks after the exposure (Fig. 30a, b). Exposures to noise at 98-
dB noise resulted in PTS of 30 dB at both 16 and 32 kHz. CaMKKβ-KO mice showed a 
significant 10 dB reduction of PTS at 16 kHz compared to their WT littermates (Fig. 30c). 
Furthermore, OHC loss was significantly decreased in the cochlea of CaMKKβ-KO mice 
2 weeks after 98 dB noise exposure. Some OHC loss began at 2 mm from the apex in 
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CaMKKβ-WT mice, while OHC loss was delayed to 5 mm in KO mice. There were 
significant differences in OHC loss at 4.5 and 5.0 mm from the apex (Fig. 30d). 
 
Noise-induced synaptopathy was not altered between CaMKKβ-KO and –WT mice  
 
In order to determine if the reduced CaMKKβ activity within knockout mice can attenuate 
noise-induced loss of IHC synaptic ribbons, ribbon particles were counted 1 h after 98-
dB noise exposure. IHCs of surface preparations from the 22 kHz region (3 mm from the 
apex) of CaMKKβ-KO mice showed similar numbers of CtBP2-labeled synaptic ribbons 
compared to WT mice after the exposure  (Fig. 31a, b).  
 
Noise-induced p-AMPKα is reduced in CaMKKβ-KO mice  
To explore the noise-induced phosphorylation of AMPKα by CaMKKβ, CaMKKβ-KO 
mice were utilized. The levels of p-AMPKα were not altered in unexposed CaMKKβ-KO 
mice as detected by Western blot and immunolabeling of surface preparations. Western 
blot using total cochlear homogenates showed an average of 30% reduction of p-
AMPKα in CaMKKβ-KO mice exposed to 98 dB noise compared to their WT littermates 
(Fig. 32b). Immunolabeling for p-AMPKα in basal OHCs of surface preparations was 





Figure 25.  Verapamil treatment reduced noise-induced hearing loss and outer hair 
cell loss. (a) Verapamil treatment reduces 98-dB noise-induced auditory threshold shifts 
at 16 and 32 kHz. Control:  n = 14, 98 dB noise:  n = 12, 98 dB noise + Saline:  n = 3, 98 
dB noise + Verapamil: n = 10. (b) Verapamil treatment reduces 106-dB noise-induced 
auditory thresholds shifts at 8 kHz. n = 6. (c) Quantitative analysis of OHCs revealed 
significant protection with verapamil treatment 14 d after the exposure. 98 dB + saline:  n 
= 5; 98 dB + verapamil:  n = 9. (c’) Representative images of OHC loss were taken from 
the basal turn at 4.5 mm from the apex, scale bar = 10 µm. Data (a, b, c) are presented 





Figure 26. Verapamil treatment did not alter noise-induced inner hair cell synaptic 
ribbon loss. 
(a) Verapamil treatment did not alter the CtBP2 (red) immunolableled synaptic ribbons in 
IHCs 1 h after 106 dB SPL BBN exposure. Representative images were taken from the 
22.6 kHz region of the middle turn, n = 4, scale bar = 10 µm. Dashed circles represent 
the outline of IHC nuclei.  (b) CtBP2 immunolabeled ribbon particles in IHCs were 






Figure 27. Noise exposure increased CaMKKβ in the organ of Corti, spiral 
ganglion neurons and spiral ligament. (a) Sections display increased localization of 
CaMKKβ immunolabeling (brown) in the organ of Corti, including OHCs and IHCs, pillar 
cells and Deiters cells, spiral ganglion neurons, stria vascularis and spiral ligament. 
Representative images were taken from the basal turn, scale bar = 10 µm, n = 3. (b) 
Western blotting of total cochlear homogenates detected no change in the levels of 






Figure 28. Noise exposure induced p-CaMKI and p-CaMKIV in basal outer hair 
cells. (a, b) The p-CaMKI (red) (a) p-CaMKIV (red) (b) immunolabeling was stronger in 
basal OHCs with phalloidin staining (green) 1 h after 98 dB SPL exposure. (a’, b’) 
Quantification of p-CaMKI (a’) and p-CaMKIV (b’) immunolabeling in OHCs displayed a 
significant increase after the noise exposure. (c) The basal region of the sensory 
epithelium displayed a tonotopic gradient of OHCs positive for p-CaMKI (red) 
immunolabeling 1 h after exposure to 106 dB SPL. (c’) Quantification of the number of p-
CaMKI positive OHCs along the basal turn (4-5 mm from the apex) confirmed a 
significant increase. n = 4. (d, e) Western blot of total cochlear homogenates showed no 
96 
 
change in the levels of p-CaMKI (d) and p-CaMKIV (e) between 98 dB noise and 
controls. GAPDH served as the sample loading control. n = 3. Data are presented as 
means + SD, * p < 0.05, n = 6. Representative images (a, b, c) were taken from the 






Figure 29. Inhibition of CaMKKβ via siRNA reduced CaMKKβ activity, noise-
induced hearing loss and outer hair cell loss. (a) Treatment with siCaMKKβ 
decreased CaMKKβ immunolabeling (red) in OHCs with phalloidin staining (green) in 
unexposed mice 72 h after silencing.  Representative images were taken from the basal 
turn, scale bar = 10 µm. (a’) Quantification of CaMKKβ levels verified significant 
decrease in OHCs. n = 3. (b) Pretreatment with siCaMKKβ reduced 98 dB SPL noise-
induced threshold shifts at 16 and 32 kHz 14 days after the exposure. 98 dB + siControl: 
n = 11; 98 dB + siCaMKKβ:  n = 7. (c) Quantitative analysis of OHCs showed significant 
protection with siCaMKKβ pretreatment 14 d after the exposure. 98 dB + siControl:  n = 
5; 98 dB + siCaMKKβ:  n = 7. (d) Representative images show DAB stained myosin VIIa 
immunolabeled OHCs at 4 mm from the apex of siControl or siCaMKKβ treated cochlea. 





Figure 30. Noise-induced hearing loss and outer hair cell loss is reduced by 
CaMKKβ-knockout. (a, b) The 92 (a) and 94 (b) dB SPL noise-induced permanent 
threshold shifts remained unchanged between CaMKKβ-KO and –WT mice 14 days 
after the exposure. 92 dB + CaMKKβ-KO:  n = 10; 92 dB + CaMKKβ-WT:  n = 4; 94 dB + 
CaMKKβ-KO:  n = 6; 94 dB + CaMKKβ-WT:  n = 7. (c) The 98 dB SPL noise-induced 
threshold shifts were decreased by 10 dB at 16 kHz by CaMKKβ-KO mice 14 days after 
the exposure. n = 6.  (d) Quantitative analysis of OHCs showed significant protection by 
CaMKKβ-KO mice at 4.5 and 5 mm from the apex 14 d after the exposure. n = 6. (e) 
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CaMKKβ mRNA copy number in total cochlear tissue homogenates was reduced in 
CaMKKβ-KO compared to WT mice. 18S served as loading control. n = 7. (f) CaMKKα 
mRNA copy number was unchanged in total cochlear tissue homogenates of CaMKKβ-
KO compared to WT littermates. 18S served as loading control. n = 7. (g) Baseline 
auditory thresholds remain unchanged between CaMKKβ-KO, -WT, and -heterozygous 






Figure 31. Noise-attenuated inner hair cell synaptic ribbons were not altered by 
CaMKKβ-knockout. (a) CaMKKβ-KO mice did not alter the CtBP2 (red) immunolableled 
synaptic ribbons in IHCs at 22.6 kHz 1 h after 98 dB SPL BBN exposure. Representative 
images were taken from the middle turn, n = 4, scale bar = 10µm. Dashed circles show 
the outline of IHC nuclei.  (b) Quantification of CtBP2 immunolabeled ribbon particles in 






Figure 32. Noise-induced phosphorylation of AMPKα is reduced in outer hair cells 
of CaMKKβ-knockout mice. (a) p-AMPKα (red) immunolabeling was reduced in OHCs 
with phalloidin staining (green) 1 h after exposure (98 dB SPL) of CaMKKβ-KO mice 
compared to wild-type littermates. n = 4. Representative images were taken from the 
basal turn, Scale bar = 10 µm. (a’) Quantification of p-AMPKα immunolabeling in OHCs 
confirmed a significant decrease. n = 4. (b)  Immunoblot of total cochlear homogenates 
shows reduction of p-AMPKα 1 h after exposure (98 dB SPL BBN) of CaMKKβ-KO mice 
compared to wild-type littermates. GAPDH served as loading control. n = 3. Data (a’, b) 










Concomitant with AMPK phosphorylation, CaMKKβ activity, as indicated by the 
phosphorylation of the CaMKKβ targets, CaMKI and CaMKIV, is increased by noise 
exposure in basal OHCs. Interestingly, the patterning associated with p-CaMKI is altered 
in a noise-intensity-dependent manner. One hour after 98 dB SPL, p-CaMKI-associated 
immunofluorescence forms a punctate pattern, the intensity of which increased in OHCs 
throughout the basal region of the sensory epithelium. One hour after 106 dB exposure, 
the p-CaMKI-immunolabeling is robustly increased in the cuticular plate of select OHCs 
in a gradient along the basal region of the sensory epithelium with the greatest number 
of p-CaMKI-positive OHCs located in the lower base where OHC death is initially 
observed (28). Such changes imply progressive overloading of calcium and calcium-
associated signaling pathways in OHCs that are undergoing and/or very near to death 
(168), as apoptotic and necrotic OHC death  occurs 1 h after 106 dB SPL BBN, but not 
after 98 dB noise exposure (39). Supporting cells and IHCs, which do not undergo cell 
death at this time point, display no p-CaMKI immunolabeling.  
This notion of noise intensity dependent changes in insults is further supported 
by the protection against noise-induced auditory threshold shifts by the inhibition of 
calcium channels via verapamil treatment. Verapamil treatment is able to effectively 
reduce the extent of NIHL induced by 98 dB noise exposure, but does not provide any 
protection from the 106 dB noise exposure, pointing to the changes in calcium-
associated signaling observed in the immunohistochemistry studies. The variations in p-
CaMKI immunolabeling pattern may be explained by intensity-dependent changes in 
calcium overloading. After the 98-dB exposure, the extent of calcium influx via 
mechanotransduction (MET) channels and VGCCs is probably limited at least in part by 
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calcium binding proteins including calmodulin that restrict intracellular free calcium 
diffusion and incite calcium-associated signaling responses (169). After the 106-dB 
exposure, the increased vibratory stimulus increases the influx of ions through both of 
the channels, overwhelming calcium chelators and elevating the intracellular free 
calcium level within OHCs. It is possible that calcium influx via MET channels (0.2 – 10% 
of MET current) may be taken up by the mitochondria and endoplasmic reticulum of the 
Hensen’s body located at the cuticular plate, which acts as a calcium store (170). The 
noise-induced release of ATP into the endolymph can activate purinergic receptors 
which promote inositol triphosphate (IP3) mediated calcium release at the Hensen’s body. 
Furthermore, the plasma membrane calcium ATPase (PMCA), the primary mechanism 
by which calcium is extruded from hair cells, is densely localized in outer hair cell 
stereocilia region (171). The sum of these activities provide an explanation for the robust 
increase of p-CaMKI specifically localized at the cuticular plate under this condition (61).  
The possible explanation for the lack of protection of auditory thresholds and 
synaptic elements by verapamil treatment at the 106-dB condition is that the 
accumulation of free calcium at the synaptic ribbon active zone overwhelms our 
protective strategies. Calcium influx primarily enters through VGCCs (>90%) at the 
basolateral surface and functions to trigger neurotransmitter release at the ribbon 
synapse. Thus, after the 106-dB exposure, the influx of calcium through VGCCs can 
lead to a surge of neurotransmitter release, resulting in excitotoxicity of the synapse. 
This introduces a two-hit pathological effect of calcium-associated pathologies at both 
the apical and basal poles of hair cells, which may overwhelm protective responses 
elicited by verapamil treatment.    
CaMKKβ appears to mediate AMPK’s contribution to the progression of NIHL. 
Inhibition of CaMKKβ by siRNA reduces 98 dB noise-induced auditory thresholds, 
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although the protection is not as great as that of siAMPKα1, Compound C, or siLKB1. 
Considering the robust reduction of CaMKKβ mRNA and p-AMPKα protein in the 
knockout mice, the 10 dB degree of protection against auditory threshold shifts and 
OHCs after noise exposure seems inadequate compared to the 30 dB protection elicited 
by CaMKKβ siRNA. Since the activation of AMPK is noise intensity-dependent, the 
relatively lower permanent threshold shift induced by the 98 dB exposure in the CaMKKβ 
knockout of C57B6/J mice may be a plausible explanation. Furthermore, studies have 
shown that the two strains differ in noise-induced cochlear pathology. The CBA/J strains 
show significant reductions in the endocochlear potential, abnormal stria vascularis and 
spiral ligament pathology acutely after noise trauma compared to the C57B6/J strains 
(172). In addition, mRNA levels of CaMKKα are not altered in the knockout mice. 
Although the activity of CaMKKα from isolated rat brain is 7-fold lower than that of 
CaMKKβ in phosphorylating AMPK (173), it does not exclude the possibility that 
CaMKKα activity is able to phosphorylate AMPK more efficiently in the absence of 
CaMKKβ, therefore, masking the effect of CaMKKβ-KO.  
Despite the partial protection of auditory thresholds observed with verapamil 
treatment and by CaMKKβ-KO mice, these therapies were unable to protect against the 
loss of synaptic ribbons. This contrasts with the evidence in Chapters 3 and 4 showing 
protection of noise-induced synaptic ribbon loss when either LKB1 or AMPK are 
targeted. It is likely that our protective strategies were overwhelmed by calcium influx 
within hair cells. This is especially likely in the case of synaptopathy, since calcium 
stimulates the excessive release of the neurotransmitter glutamate, which causes 
excitotoxicity. The activation of only a few VGCCs at the synaptic active zone is 
sufficient in eliciting both functional and pathological effects. In fact, a previous study has 
estimated that less than ten Cav1.3 VGCCs are open at a time to induce a high calcium 
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concentration nanodomain near the synaptic ribbon active zone compared to the 80 
channels localized per active zone  (174). It is likely that verapamil treatment was unable 
to completely eliminate calcium influx through all 80 channels and thus, we were unable 
to protect against the overloading of calcium. Still, we cannot exclude the possibility that 
a sub-optimal verapamil dose was utilized. Furthermore, since synaptopathy is primarily 
caused by increased calcium levels at the synaptic ribbon, rather than calcium signaling 
through CaMKKs, it is reasonable that a lack of protection was exhibited by the 
CaMKKβ-KO mice. 
Finally, the discrepancy in CaMKKβ, p-CaMKI and p-CaMKIV levels between 
immunolabeled OHCs or paraffin sections and immunoblots is possibly due to the fact 
that the cochlear tissue homogenates includes multiple cell types, including a variety of 
supporting cells, spiral ganglion neurons, and strial fibrocytes, masking changes 
occurring only in OHCs. In summary, our results demonstrate changes in calcium 
signaling in a noise intensity-dependent manner. Additionally, we demonstrate that 
inhibition of CaMKKβ either via silencing or knockout mice reduce the phosphorylation of 
AMPKα and the extent of OHC loss and NIHL.  These results suggest that calcium influx 
after noise exposure is another source in addition to intracellular ATP reduction which 












SUMMARY AND FUTURE DIRECTIONS 
 
In summary, these results present for the first time that noise-intensity dependent 
phosphorylation of AMPKα in sensory hair cells facilitates NIHL by mediating loss of IHC 
synaptic ribbons and OHCs. This noise-induced activation of AMPKα1 is facilitated by 
two pathways which converge upon AMPKα1: one initiated by changes in the 
intracellular ATP levels of the cell and activated by LKB1, and the other by CaMKKβ, 
triggered by increases in intracellular calcium. Agents that inhibit either of these 
pathways reduce the extent of AMPK phosphorylation and, subsequently, NIHL and 
OHC or synaptic ribbon loss (Fig. 33).  
 
Figure 33. Summary. Noise trauma, which induces permanent threshold shifts and 
outer hair cell loss, increases the phosphorylation of AMPKα, hair cell loss and 
subsequently hearing loss in a noise intensity-dependent fashion.  Reduction of AMPKα 
by AMPK inhibitors, Compound C or AMPKα1 siRNA, decreases p-AMPKα and protects 
from noise-induced losses of OHC and synaptic ribbons and hearing loss. 
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Concomitantly, noise trauma induces the phosphorylation of LKB1 and the CaMKKβ 
targets, p-CaMKI and p-CaMKIV. Inhibition of CaMKKβ by siRNA and knockout 
decreases the level of CaMKKβ, alleviating NIHL. Reduction of LKB1 by siRNA reduces 
the level of p-LKB1 and, subsequently, promotes the protection of noise-induced hair cell 
loss and NIHL. Finally, either inhibition of LKB1 via siRNA or knockout of CaMKKβ 
diminishes the expression of p-AMPKα, suggesting noise-induced activation of AMPK is 
mediated through both intracellular ATP reduction and calcium influx. 
This conclusion is supported by evidence demonstrating that the inhibition of 
AMPK activity with the selective AMPK inhibitor Compound C or through pretreatment 
with siAMPKα1 reduces p-AMPKα and NIHL via protection from losses of IHC synaptic 
ribbons and OHCs. Concomitant with the phosphorylation of AMPK, the activities of 
LKB1 (p-LKB1) and CaMKKβ (p-CaMKI/IV), significantly increases after noise exposure. 
Inhibition of LKB1 by siRNA and CaMKKβ via siRNA or genetic knockout reduces p-
AMPKα and the extent of NIHL, suggesting that the activation of AMPK via LKB1 and 
CaMKKβ following noise exposure contributes to the pathogenesis of NIHL. Moreover, 
the efficiency of systemic pharmacological treatment with compound C implicates a 
novel therapeutic target in prevention and amelioration of NIHL. 
The expression of total levels of AMPKα1, AMPKα2, LKB1 and CaMKKβ 
significantly increases within sensory cells and supporting cells of the organ of Corti, 
SGNs and the spiral ligament at an acute time point 1 h after 98-dB noise exposure. This 
acute and rapid change in gene expression suggests that these key homeostasis 
molecules may be primary or secondary response genes that are activated rapidly in 
response to noise insults. Immediate early genes or primary response genes are genes 
that are induced following an extracellular signal in a rapid manner (within 30 min) that 
does not require an initial round of protein synthesis. On the other hand, secondary 
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response genes are activated at later times (2 h) in response to the initial primary 
response genes, which typically encode transcription factors such as c-fos, c-jun, and 
AP-1, which increase in the organ of Corti and lateral wall tissues of the noise-exposed 
guinea pig cochlea (175).  
The current study implies that noise-induced pathological signaling events may 
vary with intensity of the noise exposure. Protection of auditory threshold shifts and 
OHCs by inhibiting AMPK (siAMPKα1, Compound C and AMPKα1-KO) and calcium-
CaMKKβ (verapamil) is significantly less effective for the more severe 106 dB noise 
condition compared to the 98 dB noise conditions. This discrepancy was most obvious 
with verapamil treatment, which does not provide protection from 106 dB noise-induced 
auditory threshold shifts, while inhibition of AMPK reduces protection. However, one 
cannot rule out that this may be an effect of a less-than-optimal concentration or drug 
treatment to target VGCCs. The noise-intensity dependent changes in signaling 
pathways is also emphasized by the alteration of the immunolabeling pattern of p-
CaMKI, between 98 and 106 dB noise conditions. As discussed in Chapter 5, the 
localization of p-CaMKI from the cytosol to the cuticular plate is suggestive of an IP3-
mediated calcium release at the Hensen’s body and implicate an initial protective 
response (mitochondrial and ER calcium uptake) or calcium extrusion via PMCA pumps, 
followed by a pathological reaction (calcium release). This evidence alludes to the 
ineffectiveness of protective cellular responses under increasing noise severities. 
Several hypotheses may explain these findings:  1) Severe noise exposure at 
106 dB might induce multiple cell death events in addition to the activation of AMPK, 
such as receptor-interacting protein kinases (39) which may bypass calcium or ATP-
initiated pathways, 2) Since inhibition of LKB1 or AMPK was able to provide greater 
protection than the blockade of calcium influx against 106 dB noise exposure, energy 
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homeostasis may contribute initially to noise-induced cochlear pathology, and the 
dysregulation of calcium homeostasis may be a secondary effect of ATP depletion, 3) 
Excessive overloading of calcium and calcium-associated cell death signaling pathways 
are more quickly activated under the 106 dB noise condition, accelerating cell death 
pathways and, thus, making therapies less effective in preventing or protecting against 
death. The third hypothesis is supported by evidence in Chapter 5 showing a lack of 
protection against noise-induced synaptopathy by inhibition of calcium influx through 
VGCCs via verapamil or inhibition of CaMKKβ via knockout mice.   
Overall, this study identifies AMPKα as a novel therapeutic target to prevent 
NIHL. Current studies have yet to establish a comprehensive target for NIHL and have 
only addressed therapies that play partial roles in protection. Because it is likely that 
NIHL is an effect of multiple pathological processes, a key goal is to identify an inclusive 
therapy. AMPK provides a prospective target that addresses many intertwining pathways 
from multiple pathological stimuli and thus delivers a promising approach. As described 
in detail in Chapter 1, several phenomena including calcium influx, ATP depletion and 
generation of ROS likely plays a role in initiating and exacerbating the pathological 
responses of sensory cells that lead to NIHL. AMPK sits at a crossroads between these 
3 events and thus may more effectively address the complexities of NIHL signaling 
pathways as a therapeutic target. However, further investigations are necessary to 
advance the current study and to address the unanswered questions. Of particular 
importance is the need to assess differences in the signaling pathways between sensory 
hair cells, which are injured by noise exposure, and supporting cells that are resistant to 
noise insults.  
As demonstrated in Chapter 3 – 5, noise-induced changes in sensory hair cells, 
such as increases in expression of total AMPKα1, AMPKα2, p-LKB1 and CaMKKβ were 
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also present in supporting cell types, despite the inconsistency in noise-induced cell fate. 
Addressing the fundamental differences in downstream signaling pathways associated 
with the activation of these molecules is necessary in order to determine key therapeutic 
targets, while limiting off-target effects. It is possible that the maintenance of 
homeostasis and ion imbalances is more effective and efficient due to the present of gap 
junctions between supporting cell types that allow for diffusion and flux of ions and 
second messengers. The buffering of calcium and potassium ions among supporting 
cells have been reported. Supporting cells take up potassium ions from the perilymph 
fluid surrounding the basolateral pole of hair cells. These potassium ions are recycled 
back to the endolymph through a series of gap junctions between supporting cells, 
fibrocytes and the cells of the stria vascularis. Dysfunction of these gap junctions can 
reduce the endocochlear potential and alter auditory function (176, 177). Additionally, 
intercellular calcium waves have been detected among Deiter’s cells in response to 
damage and extracellular ATP signals, and these calcium waves are propagated 
through connexin gap junction channels (62, 178, 179). The cell-cell communication of 
supporting cells provide increased buffering capacity compared to the sensory hair cells 
and may significantly contribute to an altered cellular response to the activities of AMPK, 
LKB1 and CaMKKβ. The increased aptitude of supporting cells to recover from a 
metabolic disruption may prevent a chronic activation of these signaling molecules that 
could cause the upregulation of pro-apoptotic genes, such as Bim, the activities of pro-
apoptotic kinases such as JNK and may increase ROS and RNS through increased nitric 
oxide synthase activity. Alternatively, AMPK activity may more quickly resolve cellular 
imbalances in supporting cells by upregulating mitochondrial biogenesis genes such as 




Moreover, changes in noise-induced signaling pathways are also apparent in the 
stria vascularis, spiral ligament, and SGNs. Chapter 3 and 4, highlight the potential 
involvement of the stria vascularis in the regulation of noise-induced energy 
homeostasis. The Na+-K+-ATPase within marginal cells of the stria vascularis transports 
potassium ions inward from the intrastrial space in order to maintain the low sodium, 
high potassium content of the endolymph. After noise insults, it is probable that 
potassium recycling is increased in order to sustain the endocochlear potential and 
maintain appropriate ionic balances, necessitating an increased demand for ATP 
production to drive these energy-consuming processes. Additionally, the release of ATP 
by marginal cells occurs after noise exposure. Extracellular ATP within the endolymph 
fluid can act upon purinergic receptors on the plasma membrane of marginal cells to 
stimulate inositol triphosphate (IP3)-mediated calcium release. This effect may in turn 
increase ATP expenditure through the activity of calcium-ATPases, which serve to 
remove the intracellular calcium from the cytosol into the ER. Altogether, these various 
mechanisms of energy expenditure may result in energy failure and ionic imbalances of 
these cell types and of the endolymph. The reduction of ATP levels probably upregulates 
the expression of p-LKB1 and AMPK as a protective response, while CaMKKβ 
expression may also increase in response to the secondary intracellular calcium release 
in the stria vascularis. Our results showing increases in expression of AMPKα1/2, p-
LKB1 and CaMKKβ support this hypothesis. Thus, reductions in auditory function as 
assessed by auditory thresholds without changes in hair cell death may be a result of 
underlying pathologies in the ionic imbalances specific to the stria vascularis. 
The pharmacological agents, Compound C and Verapamil, protect against noise-
induced damage of hearing function and hair cells, particularly in the case of Compound 
C. Despite the efficiency of this systemic treatment, advanced investigations are 
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necessary in order to examine the effectiveness of these pharmacological treatments. In 
this study, both pharmacological agents are delivered systemically to mimic a clinically 
paradigm of an oral medication. However, because both drugs are delivered at time 
points before and after the noise exposure, it is not clear whether the effects were a 
result of a protection effect, a rescue effect, or a combination of both. Further 
investigations are necessary to distinguish the functional effects of pharmacological 
treatments at time point only prior to noise exposure and only after noise exposure. 
These studies would provide information on the most effective drug delivery system for a 
clinical application. Additionally, we would better understand the protection from a 
mechanistic standpoint by determining key timing of pathological responses. 
The use of knockout mice models in the study reveale a complex relationship 
between the activation of AMPK signaling and its outcome, whether protective or 
pathological. Inhibition of AMPK via siRNA (siAMPKα1) or the use of a pharmacological 
inhibitor (Compound C) was able to reduce the extent of noise-induced cochlear deficits, 
contrasting with the worsening of cochlear deficits detected in AMPKα1-KO mice. This 
highlights the need to address the differences between a reduction in the activity of 
AMPK versus the knockout of the gene and its function. The inconsistencies may point 
to differences in the degree and timing of gene inhibition. In this study, siRNA silencing 
partially reduces AMPKα1 expression by 20% in OHCs and subsequently reduces its 
activity by 30% as determined by AMPKα phosphorylation. This partial reduction still 
allows for 70% activity of AMPK within OHCs to maintain the necessary AMPK cellular 
functions. The partial 30% reduction of its activity may be sufficient to reduce the 
pathological response AMPK may have on the cell at least to some extent. This 
contrasts with the knockout study which eliminates the AMPK gene, including its 
potentially protective function. Furthermore, the siRNA silencing acutely and transiently 
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inhibited AMPK activity. This acute expression prevents any overcompensation that the 
cell may adapt to in the knockout mouse. 
In order to more clearly understand the pathological or pro-survival function of 
AMPK in the noise-exposed cochlea, further studies are necessary to examine the 
duration of AMPK activation to identify the key timing or circumstance in which AMPK 
activation converts from a protective to pathological function. We suspect that its role 
depends on noise intensity, where exposures to noise levels that cause temporary 
hearing losses may promote cell preservation through the energy conserving activity of 
AMPK’s downstream targets, such as autophagy (71). On the other hand, exposure to 
noise that causes permanent hearing losses may lead to a sustained activation of AMPK 
as part of the cell’s protective response to the increased level of stress. Under this 
condition, the chronic activation of AMPK may alter cellular events, which may include 
the upregulation of pro-apoptotic genes as the cell prepares to eliminate the damaged 
cell. If this hypothesis is true, treatment with an AMPK activator, such as metformin, 
under temporary hearing loss noise conditions may worsen recovery from NIHL. 
Determining a balance for AMPK activation and inhibition may be a key strategy for 
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